id,pmid,year,seq,MAP,name,cter,nter,lyn_cyc,ldmix,non_nat,len,nature,activity,source,origin,exp_str,non_hem,dssp,smiles
5149,25494332,2014,RFRRLRKKWRKRLKKI,RFRRLRKKWRKRLKKI{ct:Amid},T9W,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibiofilm",50 % Hemolysis at >256 µM,Human,Mutant Peptide,α-Helix,NA,CCTTTTTTGGGTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
5370,25997127,2015,LAANFLPQILCKIARKC,LAANFLPQILCKIARKC{ct:Amid},B1CTcu5-LIAG,Amidation,Free,Linear,L,None,17,"Antibacterial, Antibiofilm",30 % Hemolysis at 12.5 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCSSHHIIIIIHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5371,25997127,2015,KIAGLAANFLPQILCKIARKC,KIAGLAANFLPQILCKIARKC{ct:Amid},B1CTcu5K,Amidation,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",15 % Hemolysis at 25 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCCCCHHHHHHHHHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5372,25997127,2015,WIAGLAANFLPQILCKIARKC,WIAGLAANFLPQILCKIARKC{ct:Amid},B1CTcu5W,Amidation,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",39.11 % Hemolysis at 100 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCTTTHHHHHHHHTTTSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5373,25997127,2015,RIAGLAANFLPQILCKIARKC,RIAGLAANFLPQILCKIARKC{ct:Amid},B1CTcu5R,Amidation,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",19.4 % Hemolysis at 25 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCCCGGGGHHIIIIIHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5374,25997127,2015,HIAGLAANFLPQILCKIARKC,HIAGLAANFLPQILCKIARKC{ct:Amid},B1CTcu5H,Amidation,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",30.4 % Hemolysis at 50 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCSCHHHHHIIIIIHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5381,25997127,2015,LIAGLAANFLPQILCKIARKC,LIAGLAANFLPQILCKIARKC{ct:Amid},DB1CTcu5,Amidation,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",40.22 % Hemolysis at 25 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCTTHHHIIIIIIIHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
6617,27606830,2016,C16-KGGK,{conj:CH3(CH2)14CO}KGGK{ct:Amid},C16-KGGK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<20 % Hemolysis at 5 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6618,27606830,2016,CH3(CH2)14CO-KGGK,{conj:CH3(CH2)14CO}KGGK{ct:Amid},C16-KGGK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<20 % Hemolysis at 10 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6619,27606830,2016,CH3(CH2)14CO-KGGK,{conj:CH3(CH2)14CO}KGGK{ct:Amid},C16-KGGK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,20 % Hemolysis at 20 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6620,27606830,2016,CH3(CH2)14CO-KGGK,{conj:CH3(CH2)14CO}KGGK{ct:Amid},C16-KGGK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,>40 % Hemolysis at 50 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6621,27606830,2016,CH3(CH2)14CO-KGGK,{conj:CH3(CH2)14CO}KGGK{ct:Amid},C16-KGGK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<80 % Hemolysis at 100 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6622,27606830,2016,CH3(CH2)14CO–KkK,{conj:CH3(CH2)14CO}KK{d}K{ct:Amid},C16-KKK,Amidation,16C- palmitate,Linear,L,16C = palmitate,3,Antibacterial and Antibiofilm,<20 % Hemolysis at 5 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6623,27606830,2016,CH3(CH2)14CO–KkK,{conj:CH3(CH2)14CO}KK{d}K{ct:Amid},C16-KKK,Amidation,16C- palmitate,Linear,L,16C = palmitate,3,Antibacterial and Antibiofilm,20 % Hemolysis at 10 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6624,27606830,2016,CH3(CH2)14CO–KkK,{conj:CH3(CH2)14CO}KK{d}K{ct:Amid},C16-KKK,Amidation,16C- palmitate,Linear,L,16C = palmitate,3,Antibacterial and Antibiofilm,>20 % Hemolysis at 20 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6625,27606830,2016,CH3(CH2)14CO–KkK,{conj:CH3(CH2)14CO}KK{d}K{ct:Amid},C16-KKK,Amidation,16C- palmitate,Linear,L,16C = palmitate,3,Antibacterial and Antibiofilm,40 % Hemolysis at 50 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6626,27606830,2016,CH3(CH2)14CO–KkK,{conj:CH3(CH2)14CO}KK{d}K{ct:Amid},C16-KKK,Amidation,16C- palmitate,Linear,L,16C = palmitate,3,Antibacterial and Antibiofilm,<60 % Hemolysis at 100 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6627,27606830,2016,CH3(CH2)14CO—KAaK,{conj:CH3(CH2)14CO}KAA{d}K{ct:Amid},C16-KAAK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<20 % Hemolysis at 5 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6628,27606830,2016,CH3(CH2)14CO—KAaK,{conj:CH3(CH2)14CO}KAA{d}K{ct:Amid},C16-KAAK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<20 % Hemolysis at 10 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6629,27606830,2016,CH3(CH2)14CO—KAaK,{conj:CH3(CH2)14CO}KAA{d}K{ct:Amid},C16-KAAK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<20 % Hemolysis at 20 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6630,27606830,2016,CH3(CH2)14CO—KAaK,{conj:CH3(CH2)14CO}KAA{d}K{ct:Amid},C16-KAAK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,20 % Hemolysis at 50 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6631,27606830,2016,CH3(CH2)14CO—KAaK,{conj:CH3(CH2)14CO}KAA{d}K{ct:Amid},C16-KAAK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<40 % Hemolysis at 100 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6632,27606830,2016,CH3(CH2)14CO–KLlK,{conj:CH3(CH2)14CO}KLL{d}K{ct:Amid},C16-KLLK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<20 % Hemolysis at 5 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6633,27606830,2016,CH3(CH2)14CO–KLlK,{conj:CH3(CH2)14CO}KLL{d}K{ct:Amid},C16-KLLK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<20 % Hemolysis at 10 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6634,27606830,2016,CH3(CH2)14CO–KLlK,{conj:CH3(CH2)14CO}KLL{d}K{ct:Amid},C16-KLLK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,20 % Hemolysis at 20 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6635,27606830,2016,CH3(CH2)14CO–KLlK,{conj:CH3(CH2)14CO}KLL{d}K{ct:Amid},C16-KLLK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<40 % Hemolysis at 50 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
6636,27606830,2016,CH3(CH2)14CO–KLlK,{conj:CH3(CH2)14CO}KLL{d}K{ct:Amid},C16-KLLK,Amidation,16C- palmitate,Linear,L,16C = palmitate,4,Antibacterial and Antibiofilm,<50 % Hemolysis at 100 μg/ml,Sheep,Lipopeptides,NA,NA,NA,NA
7165,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 8 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7166,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 15.6 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7167,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 31.2 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7168,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 62.5 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7169,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 125 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7170,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 250 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7171,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 500 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7172,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",<10 % Hemolysis at 1000 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
8278,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P2,Free,Free,Linear,L,None,12,Antibiofilm,0.84 ± 1.42 % Hemolysis at 1 μg/ml,Human,Brevibacillus Strain,α-Helix,Non-hemolytic,CCCCCCCCC,CSCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
8279,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P3,Free,Free,Linear,L,None,12,Antibiofilm,0 % Hemolysis at 2 μg/ml,Human,Brevibacillus Strain,α-Helix,Non-hemolytic,NA,CSCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
8280,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P4,Free,Free,Linear,L,None,12,Antibiofilm,0 % Hemolysis at 4 μg/ml,Human,Brevibacillus Strain,α-Helix,Non-hemolytic,NA,CSCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
8281,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P5,Free,Free,Linear,L,None,12,Antibiofilm,0 % Hemolysis at 8 μg/ml,Human,Brevibacillus Strain,α-Helix,Non-hemolytic,CCCTTSSCCSCSGGGTSCC,CSCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
8282,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P6,Free,Free,Linear,L,None,12,Antibiofilm,<10 % Hemolysis at 16 μg/ml,Human,Brevibacillus Strain,α-Helix,Non-hemolytic,CTTHHHHTTTC,CSCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
8283,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P7,Free,Free,Linear,L,None,12,Antibiofilm,10 % Hemolysis at 32 μg/ml,Human,Brevibacillus Strain,α-Helix,NA,CTTHHHHTTTC,CSCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
8284,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P8,Free,Free,Linear,L,None,12,Antibiofilm,9.92 ± 1.04 % Hemolysis at 64 μg/ml,Human,Brevibacillus Strain,α-Helix,NA,NA,CSCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
8285,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P9,Free,Free,Linear,L,None,12,Antibiofilm,16.62 ± 0.85 % Hemolysis at 128 μg/ml,Human,Brevibacillus Strain,α-Helix,NA,NA,CSCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
8286,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P10,Free,Free,Linear,L,None,12,Antibiofilm,<40 % Hemolysis at 256 μg/ml,Human,Brevibacillus Strain,α-Helix,NA,NA,CSCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
8287,37810790,2023,MFLVVKVLKYVV,MFLVVKVLKYVV,P11,Free,Free,Linear,L,None,12,Antibiofilm,72.03 ± 5.61 % Hemolysis at 512 μg/ml,Human,Brevibacillus Strain,α-Helix,NA,NA,CSCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
8443,38276499,2024,AGLGKIGALIQKVIAKYKA,AGLGKIGALIQKVIAKYKA,LC-AMP-F1,Free,Free,Linear,L,None,21,Antimicrobial and Antibiofilm,0 % Hemolysis at 5-160 µM,Rabbit,Wolf Spider Lycosa Coelestis,α-Helical,Non-hemolytic,CCGGGSHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
8468,38755634,2024,FLVKLIL,FLVKLIL{ct:Amid},BiF,Amidation,Free,Linear,L,None,7,"Antimicrobial, Antibiofilm",10 % Hemolysis at 15.63 μg/ml,Human,Synthetic,α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
8469,38755634,2024,FLVKLILKILRR,FLVKLILKILRR{ct:Amid},BiF2,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",10 % Hemolysis at 1.95 μg/ml,Human,Derivative Of Bif,α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
8470,38755634,2024,FLVKLIKKILRR,FLVKLIKKILRR{ct:Amid},BiF2_7K,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",10 % Hemolysis at 15.63 μg/ml,Human,Derivative Of Bif,α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
8471,38755634,2024,FLVKKIKKILRR,FLVKKIKKILRR{ct:Amid},BiF2_5K7K,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",10 % Hemolysis at >250 μg/ml,Human,Lysine-Substituted Hybrid Peptide,α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC
8651,37760693,2024,FLWRISKFLGKKL,FLWRISKFLGKKL{ct:Amid},HRZN-13,Amidation,Free,Linear,L,None,13,Antibacterial/ Antibiofilm,0.7 % Hemolysis at 100 μg/ml,Human,Sythesized,α-Helical,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
8652,37760693,2024,FLWRISKFLGRKL,FLWRISKFLGRKL{ct:Amid},HRZN-14,Amidation,Free,Linear,L,None,13,Antibacterial/ Antibiofilm,5.6 % Hemolysis at 100 μg/ml,Human,Sythesized,α-Helical,Non-hemolytic,CCSSSHHHHHHHHHHHHHHHHHCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
8653,37760693,2024,FLPWISKFLGKIL,FLPWISKFLGKIL{ct:Amid},HRZN-15,Amidation,Free,Linear,L,None,13,Antibacterial/ Antibiofilm,100 % Hemolysis at 100 μg/ml,Human,Sythesized,α-Helical,NA,CCCCHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
8654,37760693,2024,FLPWISKFLGKIL,FLPWISKFLGKIL{ct:Amid},HRZN-15,Amidation,Free,Linear,L,None,13,Antibacterial/ Antibiofilm,8.6 % Hemolysis at 10 μg/ml,Human,Sythesized,α-Helical,NA,CCHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
8655,37760693,2024,FLKKIWKLLGKLL,FLKKIWKLLGKLL{ct:Amid},HRZN-16,Amidation,Free,Linear,L,None,13,Antibacterial/ Antibiofilm,100 % Hemolysis at 100 μg/ml,Human,Sythesized,α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
8656,37760693,2024,FLKKIWKLLGKLL,FLKKIWKLLGKLL{ct:Amid},HRZN-16,Amidation,Free,Linear,L,None,13,Antibacterial/ Antibiofilm,67 % Hemolysis at 10 μg/ml,Human,Sythesized,α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
8657,37760693,2024,KLWKLLKKLGRLL,KLWKLLKKLGRLL{ct:Amid},HRZN-17,Amidation,Free,Linear,L,None,13,Antibacterial/ Antibiofilm,18 % Hemolysis at 10 μg/ml,Human,Sythesized,α-Helical,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
8658,37760693,2024,KLWKLLKKLGRLL,KLWKLLKKLGRLL{ct:Amid},HRZN-17,Amidation,Free,Linear,L,None,13,Antibacterial/ Antibiofilm,74 % Hemolysis at 100 μg/ml,Human,Sythesized,α-Helical,NA,CCHHHHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
8659,37760693,2024,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL-37,Free,Free,Linear,L,None,39,Antibacterial/ Antibiofilm,5.4 % Hemolysis at 10 μg/ml,Human,Sythesized,α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
8660,37760693,2024,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL-37,Free,Free,Linear,L,None,39,Antibacterial/ Antibiofilm,22 % Hemolysis at 100 μg/ml,Human,Sythesized,α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
8898,28887200,2018,FLFTVA-Dhb,FLFTVA{nnr:Dhb}{ct:Acet},ASP-1,Acetylation,Free,Linear,L,Dhb = dehydrobutyrine,7,"Antibacterial, Anti-MRSA, Antibiofilm",~6 % Hemolysis at 128 μg/ml,Human,Bacillus Subtilis Urid 12.1,β-Sheet,Low hemolytic,NA,NA
9018,29407961,2018,dabDabDabLdabDabDabLdabDabDabLfDabDabLdabDabDabLfDabDabL,{nnr:dab}{nnr:Dab}{nnr:Dab}L{nnr:dab}{nnr:Dab}{nnr:Dab}L{nnr:dab}{nnr:Dab}{nnr:Dab}LF{d}{nnr:Dab}{nnr:Dab}L{nnr:dab}{nnr:Dab}{nnr:Dab}LF{d}{nnr:Dab}{nnr:Dab}L{nt:R6 = 4-methyl-hexanoyl}{ct:Amid},Lipopeptide-13,Amidation,R6 = 4-methyl-hexanoyl,Linear,Mix,"Dab = 2,4-diaminobutanoic acid, dab = D-2,4-diaminobutanoic acid, f = D-phenylalanine",24,"Antifungal, Antibiofilm",21 % Hemolysis at 1 mM,Mouse,Linear Battacin Analogue,NA,NA,NA,NA
9305,30004427,2018,FLFSLIRKAIGGLISAFK,FLFSLIRKAIGGLISAFK,A3,Free,Free,Linear,L,None,18,Antimicrobial and Antibiofilm activities,0 % Hemolysis at 1 µM,Human,"North African Scorpion Androctonus Amoeruxi,",α-Helix,Non-hemolytic,CGGGGGSTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
9306,30004427,2018,FLFSLIRKAIGGLISAFK,FLFSLIRKAIGGLISAFK,A3,Free,Free,Linear,L,None,18,Antimicrobial and Antibiofilm activities,0 % Hemolysis at 5 µM,Human,"North African Scorpion Androctonus Amoeruxi,",α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
9307,30004427,2018,FLFSLIRKAIGGLISAFK,FLFSLIRKAIGGLISAFK,A3,Free,Free,Linear,L,None,18,Antimicrobial and Antibiofilm activities,5.1 % Hemolysis at 10 µM,Human,"North African Scorpion Androctonus Amoeruxi,",α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
9308,30004427,2018,FLFSLIRKAIGGLISAFK,FLFSLIRKAIGGLISAFK,A3,Free,Free,Linear,L,None,18,Antimicrobial and Antibiofilm activities,16.8 % Hemolysis at 20 µM,Human,"North African Scorpion Androctonus Amoeruxi,",α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
9309,30004427,2018,FLFSLIRKAIGGLISAFK,FLFSLIRKAIGGLISAFK,A3,Free,Free,Linear,L,None,18,Antimicrobial and Antibiofilm activities,36.1 % Hemolysis at 40 µM,Human,"North African Scorpion Androctonus Amoeruxi,",α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
9310,30004427,2018,FLFSLIRKAIGGLISAFK,FLFSLIRKAIGGLISAFK,A3,Free,Free,Linear,L,None,18,Antimicrobial and Antibiofilm activities,47.9 % Hemolysis at 60 µM,Human,"North African Scorpion Androctonus Amoeruxi,",α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
9311,30004427,2018,FLFSLIRKAIGGLISAFK,FLFSLIRKAIGGLISAFK,A3,Free,Free,Linear,L,None,18,Antimicrobial and Antibiofilm activities,49.4 % Hemolysis at 80 µM,Human,"North African Scorpion Androctonus Amoeruxi,",α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
9476,30216370,2018,ILKPGGGTSGGLLGGLLGKVTSVIPGLNNI,ILKPGGGTSGGLLGGLLGKVTSVIPGLNNI,α4,Free,Free,Linear,L,None,30,Antibiofilm,0 % Hemolysis at 100 µM,Human,Human Splunc1 (Short Palate Lung And Nasal Epithelial Clone 1),Helical amphipathic structure,Non-hemolytic,CCSCSSCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O
9477,30216370,2018,ILKKWWGTSGGLLGGLLGKVTSVIKGLNNI,ILKKWWGTSGGLLGGLLGKVTSVIKGLNNI,α4M1,Free,Free,Linear,L,None,30,Antibiofilm,0 % Hemolysis at 100 µM,Human,Human Splunc1 (Short Palate Lung And Nasal Epithelial Clone 1),Helical amphipathic structure,Non-hemolytic,CCCCCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O
9520,30283025,2018,KKKKKKAAFAAWAAFAA,KKKKKKAAFAAWAAFAA{ct:Amid},6K-F17,Amidation,Free,Linear,L,None,17,"Antimicrobial, Antibiofilm",0 % Hemolysis at >500 μg/ml,Human,Synthetic Amps,NA,Non-hemolytic,CCTHHHHSSCC,C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
9521,30301180,2018,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid},Magainin 2,Amidation,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",0 % Hemolysis at 64 µM,Mouse,African Clawed Fogs Xenopus Laevis,"50% TFE and 30mM SDS = α-Helical, 10 mM sodium phosphate buffer = Random coil",Non-hemolytic,CCHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
9523,30322120,2018,FLGAVLKVAGKLVPAAICKISKKC,FLGAVLKVAGKLVPAAICKISKKC,Brevinin-1GHa,Free,Free,Linear,L,None,24,"Antibiofilm, Antibacterial, Antifungal",20 % Hemolysis at 16 µM,Horse,Frog Hylarana Guentheri,α-Helix,NA,CCBTTTBCSSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC
9695,29959905,2019,KRFIKWYNAWNEKRRVY,KRFIKWYNAWNEKRRVY{ct:Amid},CXCL14-C17,Amidation,Free,Linear,L,None,17,"Antimicrobial, Antibiofilm, Anti-inflammatory",<10 % Hemolysis at 1024 µM,Human,Human Chemokine Cxcl14,α-Helix,NA,CCCHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
9696,29959905,2019,KRFIKWYKAWNKKRRVY,KRFIKWYKAWNKKRRVY{ct:Amid},CXCL14-C17-a1,Amidation,Free,Linear,L,None,17,"Antimicrobial, Antibiofilm, Anti-inflammatory",<10 % Hemolysis at 1024 µM,Human,Analog Of Cxcl14-C17 With Substitutions,α-Helix,NA,CCSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
9697,29959905,2019,KRFIKWYKAWNKKWRKY,KRFIKWYKAWNKKWRKY{ct:Amid},CXCL14-C17-a2,Amidation,Free,Linear,L,None,17,"Antimicrobial, Antibiofilm, Anti-inflammatory",10 % Hemolysis at 480 µM,Human,Analog Of Cxcl14-C17 With Substitutions,α-Helix,NA,CCSSSSSCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
9698,29959905,2019,KRFKKWYKAWRKKWRKY,KRFKKWYKAWRKKWRKY{ct:Amid},CXCL14-C17-a3,Amidation,Free,Linear,L,None,17,"Antimicrobial, Antibiofilm, Anti-inflammatory",10 % Hemolysis at 700 µM,Human,Analog Of Cxcl14-C17 With Substitutions,α-Helix,NA,NA,C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
9699,29959905,2019,KRFIKWYNAWNEKRRVY,KRFIKWYNAWNEKRRVY{ct:Amid},CXCL14-C17,Amidation,Free,Linear,L,None,17,"Antimicrobial, Antibiofilm, Anti-inflammatory",<5 % Hemolysis at 256 µM,Human,Human Chemokine Cxcl14,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
9700,29959905,2019,KRFIKWYKAWNKKRRVY,KRFIKWYKAWNKKRRVY{ct:Amid},CXCL14-C17-a1,Amidation,Free,Linear,L,None,17,"Antimicrobial, Antibiofilm, Anti-inflammatory",<5 % Hemolysis at 256 µM,Human,Analog Of Cxcl14-C17 With Substitutions,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C
9701,29959905,2019,KRFIKWYKAWNKKWRKY,KRFIKWYKAWNKKWRKY{ct:Amid},CXCL14-C17-a2,Amidation,Free,Linear,L,None,17,"Antimicrobial, Antibiofilm, Anti-inflammatory",<5 % Hemolysis at 256 µM,Human,Analog Of Cxcl14-C17 With Substitutions,α-Helix,Non-hemolytic,CCCHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
9702,29959905,2019,KRFKKWYKAWRKKWRKY,KRFKKWYKAWRKKWRKY{ct:Amid},CXCL14-C17-a3,Amidation,Free,Linear,L,None,17,"Antimicrobial, Antibiofilm, Anti-inflammatory",<5 % Hemolysis at 256 µM,Human,Analog Of Cxcl14-C17 With Substitutions,α-Helix,Non-hemolytic,NA,C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
9757,30500360,2019,PFKLSLHL,PFKLSLHL{ct:Amid},Jelleine-I,Amidation,Free,Linear,L,None,8,"Antibiofilm, Antimicrobial",~5 % Hemolysis at 256 µM,Mouse,Royal Jelly Of Honeybees (Apis Mellifera),NA,Low hemolytic,CCHHHHHTTTTC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(=O)O
9758,30500360,2019,PFcKLSLHL,P{nnr:Fc}KLSLHL{ct:Amid},fluorine-Jelleine-I (F-J-I),Amidation,Free,Linear,L,Fc = 4-F-phe-amino acid,8,"Antibiofilm, Antimicrobial",3 % Hemolysis at 256 µM,Mouse,Jelleine-I Halogenated Derivatives,NA,Low hemolytic,NA,NA
9759,30500360,2019,PFdKLSLHL,P{nnr:Fd}KLSLHL{ct:Amid},chlorine-Jelleine-I (Cl-J-I),Amidation,Free,Linear,L,Fd = 4-Cl-phe-amino acid,8,"Antibiofilm, Antimicrobial",2 % Hemolysis at 256 µM,Mouse,Jelleine-I Halogenated Derivatives,NA,Low hemolytic,NA,NA
9760,30500360,2019,PFeKLSLHL,P{nnr:Fe}KLSLHL{ct:Amid},bromine-Jelleine-I (Br-J-I),Amidation,Free,Linear,L,Fe = 4-Br-phe-amino acid,8,"Antibiofilm, Antimicrobial",~4 % Hemolysis at 256 µM,Mouse,Jelleine-I Halogenated Derivatives,NA,Low hemolytic,NA,NA
9761,30500360,2019,PFfKLSLHL,P{nnr:Ff}KLSLHL{ct:Amid},iodine-Jelleine-I (I-J-I),Amidation,Free,Linear,L,Ff = 4-I-phe-amino acid,8,"Antibiofilm, Antimicrobial",~10 % Hemolysis at 256 µM,Mouse,Jelleine-I Halogenated Derivatives,NA,Low hemolytic,NA,NA
9762,30508627,2019,GWGSFFKKAAHVGKHVGKAALTHYL,GWGSFFKKAAHVGKHVGKAALTHYL,Pleurocidin,Free,Free,Linear,L,None,25,"Antibiofilm, Antibacterial",10 % Hemolysis at 32 µM,Mouse,Fish Winter Flounder (Pseudopleuronectes Americanus),"10 mM sodium phosphate buffer = Random coil, SDS and TFE = α-Helix",NA,CCCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
9889,30521892,2019,RYAKMKRRRRRVARRHRRR,RYAKMKRRRRRVARRHRRR,PEP-NKSM,Free,Free,Linear,L,None,19,"biofilm Anti-adherent activity, Antibiofilm",12 % Hemolysis at 256 µM,Human,Derived From Human Virus Proteomes,α-Helix,Low hemolytic,CCGGGSCCC,CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
9927,31118709,2019,KFKKLFKKLSPVFKRIVQRIKDFLR,KFKKLFKKLSPVFKRIVQRIKDFLR{nt:Amid},B1,Free,Amidation,Linear,L,None,25,"Antibiofilm, Antibacterial",37 % Hemolysis at 150 µM,Human,Hybrid Peptide From Ll-37 And Bmap-27,α-Helix = 88% and Random coils = 12%,NA,CCHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
9928,30753486,2019,VNWKKILGKIIKVVK,VNWKKILGKIIKVVK{ct:Amid},LL-III,Amidation,Free,Linear,L,None,15,"Antibiofilm, Antifungal",50 % Hemolysis at 157 µM,Human,Lasioglossum Laticeps Bee Venoms,30% TFE = α-Helix,NA,CCGGGGTHHHHHHHHHHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC
9929,30753486,2019,VNWKKILGkIIKVVK,VNWKKILGK{d}IIKVVK{ct:Amid},LL-III/43,Amidation,Free,Linear,Mix,None,15,"Antibiofilm, Antifungal",50 % Hemolysis at 400 µM,Human,Derived From Ll-Iii But With D-Leu,30% TFE = α-Helix,NA,CCHHHHHHHHHHHTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC
9930,30753486,2019,GKWMSLLKHILK,GKWMSLLKHILK{ct:Amid},HAL-2,Amidation,Free,Linear,L,None,12,"Antibiofilm, Antifungal",50 % Hemolysis at 78 µM,Human,Halictus Sexcinctus Bee Venom,30% TFE = α-Helix,NA,CCSSCCSCTTSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
9931,30753486,2019,GKWMKLLKKILK,GKWMKLLKKILK{ct:Amid},peptide I,Amidation,Free,Linear,L,None,12,"Antibiofilm, Antifungal",50 % Hemolysis at 339 µM,Human,Analogs Of Hal-2,30% TFE = α-Helix,NA,CCSSCCSCTTSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
9932,30753486,2019,GKWMKLlKKILK,GKWMKLL{d}KKILK{ct:Amid},peptide VIII,Amidation,Free,Linear,Mix,None,12,"Antibiofilm, Antifungal",50 % Hemolysis at 400 µM,Human,Modified Hal-2,30% TFE = α-Helix,NA,CCSSCCSCTTSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O
9936,30802593,2019,MFTLKKPLLLLFFLGTINLSLCEEERNADEEERRDDPEERDVEVEKRFIVPSIFLLKKAFCIALKKC,MFTLKKPLLLLFFLGTINLSLCEEERNADEEERRDDPEERDVEVEKRFIVPSIFLLKKAFCIALKKC,Japonicin-2LF,Free,Free,Linear,L,None,67,"Antibiofilm, Antimicrobial",> 80 % Hemolysis at 64 µM,Horse,Limnonectes Fujianensis (Fujian Large-Headed Frog),"aqueous = Random coil, membrane-mimic solutions = α-Helix",NA,CCSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
10371,31199859,2019,FIGAIARLLSKIF,FIGAIARLLSKIF,BmKn-2,Free,Free,Linear,L,None,13,"Antimicrobial, Anti-cancer, Antibiofilm",100 % Hemolysis at 800 µM,Sheep,Scorpion Mesobuthus Martensii Karsch,α-Helix,NA,CCSCCHHHHHHHHHHHHHHHHHHHHHTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
10372,31199859,2019,FIGAIARLLSKI,FIGAIARLLSKI,BmKn-21,Free,Free,Linear,L,None,12,"Antibiofilm, Antibacterial",100 % Hemolysis at 800 µM,Sheep,Bmkn–2 Truncated Derivatives,NA,NA,CTTTHHHHHHHHHHHHHTTTTTTSCSCCCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
10373,31199859,2019,FIGAIARLLSK,FIGAIARLLSK,BmKn-22,Free,Free,Linear,L,None,11,"Antibiofilm, Antibacterial",10 % Hemolysis at 800 µM,Sheep,Bmkn–2 Truncated Derivatives,NA,Low hemolytic,CTTTHHHHHHHHHHHHHTTTSSTTCCCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O
10374,31199859,2019,FIGAIARLLS,FIGAIARLLS,BmKn-23,Free,Free,Linear,L,None,10,"Antibiofilm, Antibacterial",5 % Hemolysis at 800 µM,Sheep,Bmkn–2 Truncated Derivatives,NA,Non-hemolytic,CHHHHHHHHHTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O
10375,31199859,2019,FIGAIARLL,FIGAIARLL,BmKn-24,Free,Free,Linear,L,None,9,"Antibiofilm, Antibacterial",0 % Hemolysis at 800 µM,Sheep,Bmkn–2 Truncated Derivatives,NA,Non-hemolytic,CTTTHHHHHHHHHHHHHTTTTTTSCSCCCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
10376,31199859,2019,FIGAIARL,FIGAIARL,BmKn-25,Free,Free,Linear,L,None,8,"Antibiofilm, Antibacterial",10 % Hemolysis at 800 µM,Sheep,Bmkn–2 Truncated Derivatives,NA,Low hemolytic,CTTTHHHHHHHHHHHHHTTTSSTTCCCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
10377,31199859,2019,FIGAIAR,FIGAIAR,BmKn-26,Free,Free,Linear,L,None,7,"Antibiofilm, Antibacterial",0 % Hemolysis at 800 µM,Sheep,Bmkn–2 Truncated Derivatives,NA,Non-hemolytic,CHHHHHHHHHTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10382,31242693,2019,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT{ct:OH},Ranatuerin-2Pb,OH,Free,Linear,L,None,34,"Antimicrobial, Antibiofilm",50 % Hemolysis at 16.11 µM,Horse,Frog Rana Pipiens,"50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1) = α-Helix",NA,CCCCCCSTTCSSCSCCCSCSCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O
10383,31242693,2019,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC{ct:OH},RPa,OH,Free,Linear,L,None,32,"Antimicrobial, Antibiofilm",50 % Hemolysis at 63.9 µM,Horse,Truncated Analogues Of Ranatuerin-2Pb,"50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1) = α-Helix",NA,CEESSSEECCTTCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O
10384,31242693,2019,SFLTTVKKLVTNLAAL,SFLTTVKKLVTNLAAL{ct:Amid},RPb,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibiofilm",50 % Hemolysis at 178 µM,Horse,Truncated Analogues Of Ranatuerin-2Pb,"50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1) = α-Helix",NA,CCBCCSSSSSBSCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
10385,31242693,2019,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT{ct:OH},Ranatuerin-2Pb,OH,Free,Linear,L,None,34,"Antimicrobial, Antibiofilm",20 % Hemolysis at 8 µM,Horse,Frog Rana Pipiens,"50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1) = α-Helix",NA,CCCCCCSTTCSSCSCCCSCSCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O
10386,31242693,2019,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC{ct:OH},RPa,OH,Free,Linear,L,None,32,"Antimicrobial, Antibiofilm",20 % Hemolysis at 32 µM,Horse,Truncated Analogues Of Ranatuerin-2Pb,"50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1) = α-Helix",NA,CEESSSEECCTTCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O
10387,31242693,2019,SFLTTVKKLVTNLAAL,SFLTTVKKLVTNLAAL{ct:Amid},RPb,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibiofilm",20 % Hemolysis at 64 µM,Horse,Truncated Analogues Of Ranatuerin-2Pb,"50% TFE/H2O = α-Helix, membrane mimicking liposomes(POPC/POPG 1:1, POPE/POPG 3:1) = α-Helix",NA,CCBCCSSSSSBSCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)O
10406,31016969,2019,KKLRLKIAFK,KKLRLKIAFK,PaDBS1R6F10,Free,Free,Linear,L,None,10,"Antibiofilm, Antibacterial, Anti-infective",50 % Hemolysis at >100 µM,Human,Derived From A Pyrobaculum Aerophilum Ribosomal Protein,NA,Low hemolytic,CCCCCCSCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
10419,31363941,2019,KWKKLLKKPLLKKLLKKL,KWKKLLKKPLLKKLLKKL{ct:Amid},P5,Amidation,Free,Linear,L,None,18,"Antibacterial, Antibiofilms",14 % Hemolysis at 100 µM,mouse,Cecropin A-Magainin 2 Hybrid Analog Peptide,"10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix",NA,CCTTTTCSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)O
10420,31363941,2019,KWKKLLKKPLLKKLLK,KWKKLLKKPLLKKLLK{ct:Amid},P5-CT1,Amidation,Free,Linear,L,None,16,"Antibacterial, Antibiofilms",0 % Hemolysis at 100 µM,mouse,Truncated Peptides P5,"10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix",Non-hemolytic,CCCCTTTSSSSTTSCCCCSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10421,31363941,2019,KWKKLLKKPLLKKL,KWKKLLKKPLLKKL{ct:Amid},P5-CT2,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilms",0 % Hemolysis at 100 µM,mouse,Truncated Peptides P5,"10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = Random coil, LTA and LPS = Random coil",Non-hemolytic,CCCCTTTSSSSTTSCCCCSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)O
10423,31363941,2019,KKLLKKPLLKKLLKKL,KKLLKKPLLKKLLKKL{ct:Amid},P5-NT1,Amidation,Free,Linear,L,None,16,"Antibacterial, Antibiofilms",0 % Hemolysis at 100 µM,mouse,Truncated Peptides P5,"10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix",Non-hemolytic,CCCCTTTSSSSTTSCCCCSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
10424,31363941,2019,LLKKPLLKKLLKKL,LLKKPLLKKLLKKL{ct:Amid},P5-NT2,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilms",0 % Hemolysis at 100 µM,mouse,Truncated Peptides P5,"10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix",Non-hemolytic,CCCCTTTSSSSTTSCCCCSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)O
10425,31363941,2019,KKPLLKKLLKKL,KKPLLKKLLKKL{ct:Amid},P5-NT3,Amidation,Free,Linear,L,None,12,"Antibacterial, Antibiofilms",0 % Hemolysis at 100 µM,mouse,Truncated Peptides P5,"10 mM SP bufer = Random coil, 30 mM SDS and 50% TFE = α-Helix, LTA and LPS = α-Helix",Non-hemolytic,CCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
10456,31321199,2019,KDRPKKPGLCPLIWWLIIKVG,KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid},omw1,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",4.30 ± 0.15 % Hemolysis at 31.25 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,Low hemolytic,CTHHHHHHHTHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
10457,31321199,2019,KDRPKKPGLCPLIWWLIIKVG,KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid},omw1,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",4.82 ± 0.33 % Hemolysis at 62.5 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,Low hemolytic,CTTHHHHSSGGGSGGGHHHHTTCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
10458,31321199,2019,KDRPKKPGLCPLIWWLIIKVG,KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid},omw1,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",6.58 ± 0.25 % Hemolysis at 125 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,NA,CCCSSCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
10459,31321199,2019,KDRPKKPGLCPLIWWLIIKVG,KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid},omw1,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",10.01 ± 0.52 % Hemolysis at 250 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,NA,CCTTHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
10460,31321199,2019,KDRPKKPGLCPLIWWLIIKVG,KDRPKKPGLCPLIWWLIIKVG{nt:Amid}{ct:Amid},omw1,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",14.46 ± 1.82 % Hemolysis at 500 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,NA,CHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC
10461,31321199,2019,KDRPKKPGLCPAAKKAAAAKA,KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid},omw2,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",1.26 ± 0.38 % Hemolysis at 31.25 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,Low hemolytic,CHHHHHHHTTTCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
10462,31321199,2019,KDRPKKPGLCPAAKKAAAAKA,KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid},omw2,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",3.12 ± 0.38 % Hemolysis at 62.5 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,Low hemolytic,CTHHHHTGGGTTC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
10463,31321199,2019,KDRPKKPGLCPAAKKAAAAKA,KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid},omw2,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",2.32 ± 0.43 % Hemolysis at 125 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,Low hemolytic,CHHHHHHHHHHTC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
10464,31321199,2019,KDRPKKPGLCPAAKKAAAAKA,KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid},omw2,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",4.82 ± 0.74 % Hemolysis at 250 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,Low hemolytic,CHHHHHHGGGTCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
10465,31321199,2019,KDRPKKPGLCPAAKKAAAAKA,KDRPKKPGLCPAAKKAAAAKA{nt:Amid}{ct:Amid},omw2,Amidation,Amidation,Linear,L,None,21,"Antibiofilm, Antibacterial",9.27 ± 0.27 % Hemolysis at 500 μg/ml,Human,"Derived From Snake Venom Peptide, Omwaprin(Oxyuranus Microlepidotus)",NA,NA,CHHHHHHHHHHTC,CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
10467,31426323,2019,ALWKTLLKHVGKAAGKAALNAVTDMVNQ,ALWKTLLKHVGKAAGKAALNAVTDMVNQ{ct:Amid},Der-PS4,Amidation,Free,Linear,L,None,28,"Antimicrobial, Antibiofilm, Antiproliferative, Anticancer",50 % Hemolysis at 128 µM,Horse,"Waxy Monkey Tree Frog, Phyllomedusa Sauvagii","mimetic environment(DOPE, DOPC and DOPG, TFE) = α-Helix",NA,CHHHHGGGGGTTC,CSCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)N)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C
10597,31319057,2019,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL-37,Free,Free,Linear,L,None,37,"Antimicrobial, Antibiofilm",50 % Hemolysis at 170 µM,Human,Human Innate Immune Peptide Ll-37,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
10598,31319057,2019,GFKRIVQRIKDFLRNLV,GFKRIVQRIKDFLRNLV{ct:Amid},GF-17,Amidation,Free,Linear,L,None,17,"Antimicrobial, Antibiofilm",50 % Hemolysis at 180 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
10599,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17tF-W,Amidation,Free,Linear,Mix,"X1 = 4-t-butylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",12.1 % Hemolysis at 220 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10600,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17mF-W,Amidation,Free,Linear,Mix,"X1 = 4-methylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",7.1 % Hemolysis at 220 µM,Human,Synthetic Ll-37 Derived Peptides,NA,Low hemolytic,NA,NA
10601,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17W2,Amidation,Free,Linear,Mix,"X1 = 4-methylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",8 % Hemolysis at 220 µM,Human,Synthetic Ll-37 Derived Peptides,NA,Low hemolytic,NA,NA
10602,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17tF2,Amidation,Free,Linear,Mix,"X1 = 4-t-butylphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",32.5 % Hemolysis at 220 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10603,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17B-tF,Amidation,Free,Linear,Mix,"X1 = biphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",30.2 % Hemolysis at 220 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10604,31319057,2019,GX1KRlVQRlKD X2lRKLV,G{nnr:X1}KRL{d}VQRL{d}KD {nnr:X2}L{d}RKLV{ct:Amid},17BIPHE2,Amidation,Free,Linear,Mix,"X1 = biphenylalanine, X2 = biphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",61.5 % Hemolysis at 220 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10605,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17tF-W,Amidation,Free,Linear,Mix,"X1 = 4-t-butylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",50 % Hemolysis at > 440 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10606,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17mF-W,Amidation,Free,Linear,Mix,"X1 = 4-methylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",50 % Hemolysis at > 440 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10607,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17W2,Amidation,Free,Linear,Mix,"X1 = 4-methylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",50 % Hemolysis at > 440 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10608,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17tF2,Amidation,Free,Linear,Mix,"X1 = 4-t-butylphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",50 % Hemolysis at > 440 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10609,31319057,2019,GX1KRlVQRlKDWlRKLV,G{nnr:X1}KRL{d}VQRL{d}KDWL{d}RKLV{ct:Amid},17B-tF,Amidation,Free,Linear,Mix,"X1 = biphenylalanine, X2 = 4-t-butylphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",50 % Hemolysis at > 440 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10610,31319057,2019,GX1KRlVQRlKD X2lRKLV,G{nnr:X1}KRL{d}VQRL{d}KD {nnr:X2}L{d}RKLV{ct:Amid},17BIPHE2,Amidation,Free,Linear,Mix,"X1 = biphenylalanine, X2 = biphenylalanine, l = D amino acid",17,"Antimicrobial, Antibiofilm",50 % Hemolysis at 180 µM,Human,Synthetic Ll-37 Derived Peptides,NA,NA,NA,NA
10613,31448597,2019,KWKLFKKIGAVLKVL,KWKLFKKIGAVLKVL{ct:Amid},CM15,Amidation,Free,Linear,L,None,15,"Antibacterial, Antibiofilm",40 ± 5 % Hemolysis at 2 µM,mouse,Derived From Citropin1.1,α-Helix,NA,CCSCSCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
10614,31448597,2019,GGHKWKLFKKIGAVLKVL,GGHKWKLFKKIGAVLKVL{ct:Amid},GGH-CM15,Amidation,Free,Linear,L,None,18,"Antibacterial, Antibiofilm",29 ± 2 % Hemolysis at 2 µM,mouse,Variant Of Cm15,α-Helix,NA,CCSCSCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
10615,31448597,2019,VIHKWKLFKKIGAVLKVL,VIHKWKLFKKIGAVLKVL{ct:Amid},VIH-CM15,Amidation,Free,Linear,L,None,18,"Antibacterial, Antibiofilm",29 ± 3 % Hemolysis at 1 µM,mouse,Variant Of Cm15,α-Helix,NA,CCSCSCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
10616,31448597,2019,GLFDVIKKVASVIGGL,GLFDVIKKVASVIGGL{ct:Amid},citropin1.1,Amidation,Free,Linear,L,None,16,"Antibacterial, Antibiofilm",16.5 ± 3 % Hemolysis at 10 µM,mouse,Tree Frog Of The Litora Genus,α-Helix,NA,CCSCSCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O
10617,31448597,2019,GGHGLFDVIKKVASVIGGL,GGHGLFDVIKKVASVIGGL{ct:Amid},GGH-citropin1.1,Amidation,Free,Linear,L,None,19,"Antibacterial, Antibiofilm",0.2 ± 0.05 % Hemolysis at 34 µM,mouse,Modified Citropin1.1,α-Helix,Non-hemolytic,CGGGTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O
10618,31448597,2019,VIHGLFDVIKKVASVIGGL,VIHGLFDVIKKVASVIGGL{ct:Amid},VIH-citropin1.1,Amidation,Free,Linear,L,None,19,"Antibacterial, Antibiofilm",0.9 ± 0.1 % Hemolysis at >33 µM,mouse,Modified Citropin1.1,α-Helix,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)CC)C(C)C
10633,31207076,2019,LRWWLWKLLRRMR,LRWWLWKLLRRMR{ct:Amid},LR-10,Amidation,Free,Linear,L,None,13,"Antibacterial. Antibiofilm,",0 % Hemolysis at 3.3 µM(PBS),Rabbit,"Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,)",NA,Non-hemolytic,CHHHHHHHHTCTTSHHHHHHHHHGGGCC,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10634,31207076,2019,LRWWLWKLLRRMR,LRWWLWKLLRRMR{ct:Amid},LR-10,Amidation,Free,Linear,L,None,13,"Antibacterial. Antibiofilm,",0 % Hemolysis at 3.3 µM(IGF),Rabbit,"Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,)",NA,Non-hemolytic,CTHHHHHHHHHHHHCCCCC,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10635,31207076,2019,LRWWLWKLLRRMR,LRWWLWKLLRRMR{ct:Amid},LR-10,Amidation,Free,Linear,L,None,13,"Antibacterial. Antibiofilm,",>80 % Hemolysis at 52.3 µM(PBS),Rabbit,"Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,)",NA,NA,CHHHHTCCCC,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10636,31207076,2019,LRWWLWKLLRRMR,LRWWLWKLLRRMR{ct:Amid},LR-10,Amidation,Free,Linear,L,None,13,"Antibacterial. Antibiofilm,",100 % Hemolysis at 52.3 µM(IGF),Rabbit,"Analogue Of Lr‐1 (Reutericin 6 And/Or Gassericin A,)",NA,NA,NA,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10641,31635388,2019,GLWSKIKDAAKTAGKAALGFVNEMV,GLWSKIKDAAKTAGKAALGFVNEMV,DPT9,Free,Free,Linear,L,None,25,"Antimicrobial, Antibiofilm, Anticancer",50 % Hemolysis at 210 µM,Horse,Derived From Frog Phyllomedusa Tarsius Dpt9,NA,NA,CGGGHHHHTTSCSTTTTTGGGGSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
10642,31635388,2019,GLWSKIKKAAKTAGKAALGFVNKMV,GLWSKIKKAAKTAGKAALGFVNKMV,"K8, 23-DPT9",Free,Free,Linear,L,None,25,"Antimicrobial, Antibiofilm, Anticancer",50 % Hemolysis at 107 µM,Horse,Analogue And Modified Dtp9,NA,Low hemolytic,CCCSSSSTTTCSCCTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)[C@@H](C)O
10669,31752079,2019,FLQHIIGALGHLF,FLQHIIGALGHLF,GHa,Free,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",10 % Hemolysis at 20 µM,Human,Frog Hylarana Guentheri,α-Helix,NA,CGGGTHHHHTTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
10670,31752079,2019,FLQKIIGALGKLF,FLQKIIGALGKLF,GHaK,Free,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",10 % Hemolysis at 16 µM,Human,Gha Analogues,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
10671,31752079,2019,FLQKIIGALGHLF,FLQKIIGALGHLF,GHa4K,Free,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",10 % Hemolysis at 26 µM,Human,Gha Analogues,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
10672,31752079,2019,FLQHIIGALGKLF,FLQHIIGALGKLF,GHa11K,Free,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",10 % Hemolysis at 15 µM,Human,Gha Analogues,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
10673,31752079,2019,FLQHIIGALGHLF,FLQHIIGALGHLF,GHa,Free,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",50 % Hemolysis at 115 µM,Human,Frog Hylarana Guentheri,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
10674,31752079,2019,FLQKIIGALGKLF,FLQKIIGALGKLF,GHaK,Free,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",50 % Hemolysis at 66 µM,Human,Gha Analogues,α-Helix,NA,CCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
10675,31752079,2019,FLQKIIGALGHLF,FLQKIIGALGHLF,GHa4K,Free,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",50 % Hemolysis at 69 µM,Human,Gha Analogues,α-Helix,NA,CCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
10676,31752079,2019,FLQHIIGALGKLF,FLQHIIGALGKLF,GHa11K,Free,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",50 % Hemolysis at 40 µM,Human,Gha Analogues,α-Helix,NA,CCSSSSCCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
10703,31520928,2019,YIRKIRRFFKKLKKILKK,YIRKIRRFFKKLKKILKK{ct:Amid},P5,Amidation,Free,Linear,L,None,18,"Antibacterial, Antibiofilm",10 % Hemolysis at 640 μg/ml,Murine,H5-Derived Peptides,Helical,Low hemolytic,CCGGGTTTHHHHTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10707,31520928,2019,SYERKINRHFKTLKKNLKKK,SYERKINRHFKTLKKNLKKK{ct:Amid},P9,Amidation,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",10 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,NA,Low hemolytic,CCTTTHHHHHHHTCSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
10716,31520928,2019,YIRKIRRFFKKLKKILKK,YIRKIRRFFKKLKKILKK{ct:Amid},P5,Amidation,Free,Linear,L,None,18,"Antibacterial, Antibiofilm",50 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,Helical,Low hemolytic,CCTHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
10720,31520928,2019,SYERKINRHFKTLKKNLKKK,SYERKINRHFKTLKKNLKKK{ct:Amid},P9,Amidation,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",50 % Hemolysis at >640 μg/ml,Murine,H5-Derived Peptides,NA,Low hemolytic,CCSSHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
10797,31549575,2019,GVTFNALKGVAKTVAAQLLKTAR,GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid},Brevinin-GR23,Amidation,Free,Linear,L,None,23,"Antimicrobial, Antibiofilm",0.13 % Hemolysis at 25 µM,Human,Frog Hylarana Guentheri,"aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical",Non-hemolytic,CCSHHHHHHHHHHHHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
10798,31549575,2019,GVTFNALKGVAKTVAAQLLKTAR,GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid},Brevinin-GR23,Amidation,Free,Linear,L,None,23,"Antimicrobial, Antibiofilm",0.23 % Hemolysis at 50 µM,Human,Frog Hylarana Guentheri,"aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical",Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
10799,31549575,2019,GVTFNALKGVAKTVAAQLLKTAR,GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid},Brevinin-GR23,Amidation,Free,Linear,L,None,23,"Antimicrobial, Antibiofilm",0.38 % Hemolysis at 75 µM,Human,Frog Hylarana Guentheri,"aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical",Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
10800,31549575,2019,GVTFNALKGVAKTVAAQLLKTAR,GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid},Brevinin-GR23,Amidation,Free,Linear,L,None,23,"Antimicrobial, Antibiofilm",0.75 % Hemolysis at 100 µM,Human,Frog Hylarana Guentheri,"aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical",Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
10801,31549575,2019,GVTFNALKGVAKTVAAQLLKTAR,GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid},Brevinin-GR23,Amidation,Free,Linear,L,None,23,"Antimicrobial, Antibiofilm",0.83 % Hemolysis at 150 µM,Human,Frog Hylarana Guentheri,"aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical",Non-hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
10802,31549575,2019,GVTFNALKGVAKTVAAQLLKTAR,GVTF{d}NALK{d}GVAK{d}TVAAQLLK{d}TAR{cT{d}:Amid},Brevinin-GR23,Amidation,Free,Linear,L,None,23,"Antimicrobial, Antibiofilm",1.6 % Hemolysis at 200 µM,Human,Frog Hylarana Guentheri,"aqueous = Random coil, 30 mM SDS and 50% TFE solution(MME) = α-Helical",Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
10805,31676352,2019,GLLk(C8)RIkTLL,GLLK{d}{conj:C8}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C8",Amidation,Free,Linear,Mix,C8 = C8,10,"Antibacterial, Antibiofilm",10 % Hemolysis at >256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10806,31676352,2019,GLLk(C10)RIkTLL,GLLK{d}{conj:C10}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C10",Amidation,Free,Linear,Mix,C10 = C10,10,"Antibacterial, Antibiofilm",10 % Hemolysis at 256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10807,31676352,2019,GLLk(C12)RIkTLL,GLLK{d}{conj:C12}RIK{d}TLL{ct:Amid},"Ano-D4,7-4C12",Amidation,Free,Linear,Mix,C12 = C12,10,"Antibacterial, Antibiofilm",10 % Hemolysis at 32 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",NA,NA,NA
10812,31676352,2019,GLLkRIk(C8)TLL,GLLK{d}RIK{d}{conj:C8}TLL{ct:Amid},"Ano-D4,7-7C8",Amidation,Free,Linear,Mix,C8 = C8,10,"Antibacterial, Antibiofilm",10 % Hemolysis at 256 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10813,31676352,2019,GLLkRIk(C10)TLL,GLLK{d}RIK{d}{conj:C10}TLL{ct:Amid},"Ano-D4,7-7C10",Amidation,Free,Linear,Mix,C10 = C10,10,"Antibacterial, Antibiofilm",10 % Hemolysis at 128 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",Low hemolytic,NA,NA
10814,31676352,2019,GLLkRIk(C12)TLL,GLLK{d}RIK{d}{conj:C12}TLL{ct:Amid},"Ano-D4,7-7C12",Amidation,Free,Linear,Mix,C12 = C12,10,"Antibacterial, Antibiofilm",10 % Hemolysis at 32 µM,mouse,Synthestic Amps With Conjugate Fatty Acid,"10 mM PBS (pH 7.4) = unordered, 30 mM SDS = α-helica",NA,NA,NA
10817,31676352,2019,GLLKRIKTLL,GLLKRIKTLL{ct:Amid},Anoplin,Amidation,Free,Linear,L,None,10,"Antibacterial, Antibiofilm",10 % Hemolysis at >256 µM,mouse,Venom Sac Of Solitary Spider Wasps,α-Helical,Low hemolytic,CTHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
10818,31676352,2019,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ{ct:Amid},Melittin,Amidation,Free,Linear,L,None,26,"Antibacterial, Antibiofilm",75 % Hemolysis at 2 µM,mouse,Honey Bee Apis Mellifera,α-Helical,NA,CHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
10874,31887002,2020,LKKLACRLKKLACRLKKLACR,LKKLACRLKKLACRLKKLACR{ct:Amid},ACR3,Amidation,Free,Linear,L,None,21,"Antibiofilm, Antifungal, Antibacterial",10 % Hemolysis at >128 µM,Human,Heptad Repeat Sequence Antifungal Peptide,"PBS = Random coil, PBS(208-222nm) = α-Helical, SDS/TFE = α-Helical",Low hemolytic,CCCBTTBC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
10903,31778756,2020,RIVQRIKKWLLKWKKLGY,RIVQRIKKWLLKWKKLGY,peptide 5,Free,Free,Linear,L,None,18,"Antibiofilm, Antibacterial",<10 % Hemolysis at 1024 μg/ml,mouse,Synthetic Peptide,SDS = α-Helix,Low hemolytic,CCHHHHTTHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
10904,31778756,2020,GLLRKWGKKWKEFLRRVWK,GLLRKWGKKWKEFLRRVWK,peptide 6.2,Free,Free,Linear,L,None,19,"Antibiofilm, Antibacterial",<5 % Hemolysis at 128 μg/ml,mouse,Synthetic Peptide,α-Helix,Low hemolytic,CCHHHHGGGTCC,CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
10905,31778756,2020,GLLRKWGKKWKEFLRRVWK,GLLRKWGKKWKEFLRRVWK,peptide 6.2,Free,Free,Linear,L,None,19,"Antibiofilm, Antibacterial",30 % Hemolysis at 1024 μg/ml,mouse,Synthetic Peptide,α-Helix,Low hemolytic,CCGGGTTTTTCC,CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
11316,32534825,2020,GATIRAVNSR,GATIRAVNSR,PepGAT,Free,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",0 % Hemolysis at 50 μg/ml,Rabbit,Synthetic Amps,Random coil,Non-hemolytic,CCSSCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
11317,32534825,2020,KAANRIKYFQ,KAANRIKYFQ,PepKAA,Free,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",0 % Hemolysis at 50 μg/ml,Rabbit,Synthetic Amps,Random coil,Non-hemolytic,CCSTTCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O
11318,32534825,2020,GATIRAVNSR,GATIRAVNSR,PepGAT,Free,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",0 % Hemolysis at 100 μg/ml,Rabbit,Synthetic Amps,Random coil,Non-hemolytic,CCSSCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
11319,32534825,2020,KAANRIKYFQ,KAANRIKYFQ,PepKAA,Free,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",0 % Hemolysis at 100 μg/ml,Rabbit,Synthetic Amps,Random coil,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O
11320,32534825,2020,GATIRAVNSR,GATIRAVNSR,PepGAT,Free,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",0 % Hemolysis at 250 μg/ml,Rabbit,Synthetic Amps,Random coil,Non-hemolytic,CTTTTTSTHHHHGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
11321,32534825,2020,KAANRIKYFQ,KAANRIKYFQ,PepKAA,Free,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",0 % Hemolysis at 250 μg/ml,Rabbit,Synthetic Amps,Random coil,Non-hemolytic,CCTTTGGGTTTGGGTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O
11322,32534825,2020,GATIRAVNSR,GATIRAVNSR,PepGAT,Free,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",0 % Hemolysis at 500 μg/ml,Rabbit,Synthetic Amps,Random coil,Non-hemolytic,CHHHHTHHHHHHHHHHHTTTCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C
11323,32534825,2020,KAANRIKYFQ,KAANRIKYFQ,PepKAA,Free,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",0 % Hemolysis at 500 μg/ml,Rabbit,Synthetic Amps,Random coil,Non-hemolytic,CTHHHHHHTTCSSSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)O
11511,32590058,2020,kFwSLLkKALRLwANVL,K{d}FW{d}SLLK{d}KALRLW{d}ANVL{ct:Amid},CPF-2,Amidation,Free,Linear,Mix,None,17,"Antibiofilm, Antibacterial",100 % Hemolysis at 128 μg/ml,Mouse,Cpf-C1 Analogs (Tetraploid Frog Xenopus Clivii Peracca (Pipidae) ),50% TFE = Random coil,NA,CTHHHHHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)O
11550,32967333,2020,ALWKKLLKK-Cha,ALWKKLLKK-{nnr:Cha}{ct:Amid},DMPC-10A,Amidation,Free,Linear,L,Cha = Cyclohexanylalanine,10,"Antibacterial, Antibiofilm",≥20 % Hemolysis at 128 µM,Horse,Derived From A Dermaseptin (Phyllomedusa Frogs),amphipathic environment = α-Helix,NA,NA,NA
11551,32967333,2020,AlWkkllkk-Cha,AL{d}WK{d}K{d}L{d}L{d}K{d}K{d}-{nnr:Cha}{ct:Amid},DMPC-10B,Amidation,Free,Linear,Mix,Cha = Cyclohexanylalanine,10,"Antibacterial, Antibiofilm",0 % Hemolysis at 128 µM,Horse,Modificaiton Of Dmpc-10A,TFE = α-Helix,Non-hemolytic,NA,NA
11609,33194795,2020,RFRLPFRRPPIRIHPPPFYPPFRRFL,RFRLPFRRPPIRIHPPPFYPPFRRFL{ct:Amid},ChBac3.4-NH2(caprine proline-rich bactenecin),Amidation,Free,Linear,L,None,26,"Antitumor, Antimicrobial, Antibiofilm",25 ± 2 % Hemolysis at 64 µM,Human,Domestic Goat Capra Hircus,NA,NA,CCCCCCCCSCCCCCCTTSCSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11613,33194795,2020,RFRRFRLPFRRIHPPPFVRIHPPPFYRRFL,RFRRFRLPFRRIHPPPFVRIHPPPFYRRFL{ct:Amid},RFR-ChBac3.4-1-NH2,Amidation,Free,Linear,L,None,30,"Antibacterial, Antibiofilm",<5 % Hemolysis at 64 µM,Human,Chbac3.4 Full-Lenght Variants,NA,Low hemolytic,CCCCCCCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
11619,33194795,2020,RFRRFRLPFRRPPIRIH,RFRRFRLPFRRPPIRIH{ct:Amid},RFR-ChBac3.4(1-14)-NH2,Amidation,Free,Linear,L,None,17,"Antibacterial, Antibiofilm",<5 % Hemolysis at 64 µM,Human,Chbac3.4 Truncated Variants,NA,Low hemolytic,CCCCCCSSSCHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
11624,33193152,2020,FLSLIPKIAGGIAALVKNL,FLSLIPKIAGGIAALVKNL{ct:Amid},Phylloseptin-PV1 (PPV1),Amidation,Free,Linear,L,None,19,"Antimicrobial, Antiproliferative, Antibiofilm",≥50 % Hemolysis at 32 µM,Horse,White-Lined Leaf Frog Phyllomedusa Vaillantii,"aqueous = Random coil, 50% TFE = α-Helix",NA,CHHHHGGGGGGCSHHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
11625,33193152,2020,FLSLIPKIAGGIAALVKNL,FLSLIPKIAGGIAALVKNL{ct:Amid},Phylloseptin-PV1 (PPV1),Amidation,Free,Linear,L,None,19,"Antimicrobial, Antiproliferative, Antibiofilm",≥95 % Hemolysis at 64 µM,Horse,White-Lined Leaf Frog Phyllomedusa Vaillantii,"aqueous = Random coil, 50% TFE = α-Helix",NA,CHHHHGGGGGGCSHHHHHTTCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
11654,33233541,2020,FFGSLLSLGSKLLPSVFKLFQRKKE,FFGSLLSLGSKLLPSVFKLFQRKKE{ct:Amid},Css54,Amidation,Free,Linear,L,None,25,"Antibacterial, Antibiofilm",40 % Hemolysis at 16 µM,Sheep,Scorpion Venom Of Centruroides Suffusus,"aqueous(10mM sodium phosphate) = Random coil, TFE and SDS = α-Helix",NA,CTHHHHTTTHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(C)C
11749,33296183,2021,FLKα-(4-pentenyl)-AlaLKKLL,FLK{nnr:α-(4-pentenyl)-Ala}LKKLL{ct:Amid},Feleucin-K59,Amidation,Free,Linear,L,α-(4-pentenyl)-Ala,9,"Antibacterial, Antibiofilm",≥60 % Hemolysis at 128 μg/ml,Mouse,Feleucin-K3 Analogues (Frog Bombina Orientalis),TFE = α-Helix,NA,NA,NA
11757,33532575,2021,KYKKALKKLAKLL,KYKKALKKLAKLL,L-SB1,Free,Free,Linear,L,None,13,Antibacterial. Antibiofilm,MHC at >2000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CCCCCCSCCCTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)O
11758,33532575,2021,kykkalkklakll,K{d}Y{d}K{d}K{d}A{d}L{d}K{d}K{d}L{d}A{d}K{d}L{d}L{d},D-SB1,Free,Free,Linear,D,None,13,Antibacterial. Antibiofilm,MHC at >2000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CCCCCTTSCCCCGGGHHHHHHHHHHHHHHHHTTTTCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)O
11759,33532575,2021,VQWRAIRVRVIR,VQWRAIRVRVIR,L-DJK5,Free,Free,Linear,L,None,12,Antibacterial. Antibiofilm,MHC at >2000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CCCCCTTSCCCCGGGHHHHHHHHHHHHHHHHTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
11760,33532575,2021,vqwrairvrvir,V{d}Q{d}W{d}R{d}A{d}I{d}R{d}V{d}R{d}V{d}I{d}R{d},D-DJK5,Free,Free,Linear,D,None,12,Antibacterial. Antibiofilm,MHC at 1000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
11761,33532575,2021,ILPWKWPWWPWRR,ILPWKWPWWPWRR,L-Indo,Free,Free,Linear,L,None,13,Antibacterial. Antibiofilm,MHC at 125 μg/ml,Human,Derived From Bovin,PB and 20%TFE = α-Helical,NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11762,33532575,2021,ilpwkwpwwpwrr,I{d}L{d}P{d}W{d}K{d}W{d}P{d}W{d}W{d}P{d}W{d}R{d}R{d},D-Indo,Free,Free,Linear,D,None,13,Antibacterial. Antibiofilm,MHC at 125 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,NA,CTTCCCCCCCGGGHHHHHHHHHHHHHHHHHHHHHTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
11763,33532575,2021,KLKLKLKLKLKLKLKLKKLKKLKKLKKLKKLKKLKKL,KLKLKLKLKLKLKLKLKKLKKLKKLKKLKKLKKLKKL,L-G3KL,Free,Free,Branched,L,None,37,Antibacterial. Antibiofilm,MHC at 1000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CTTCCCCCCCGGGHHHHHHHHHHHHHHHHHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11764,33532575,2021,klklklklklklklklkklkklkklkklkklkklkkl,K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d},D-G3KL,Free,Free,Branched,D,None,37,Antibacterial. Antibiofilm,MHC at 1000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CCSTTTSCSSCCCCCCSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11765,33532575,2021,OFOFOFOFKBLKBLKKLK(C10),OFOFOFOFKBLKBLKKLK{ct:C10},L-TNS18,C10,Free,Branched,L,C10,18,Antibacterial. Antibiofilm,MHC at 1000 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Non-hemolytic,CGGGGTTTTSCSCCCCCCCSCCC,NA
11766,33532575,2021,ofofofofkblkblkklk(C10),O{d}F{d}O{d}F{d}O{d}F{d}O{d}F{d}K{d}B{d}L{d}K{d}B{d}L{d}K{d}K{d}L{d}K{d}{ct:C10},D-TNS18,Free,Free,Branched,D,None,18,Antibacterial. Antibiofilm,MHC at 500 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,Low hemolytic,CCSTTTSTTCCCSSCCCCCCCCC,NA
11767,33532575,2021,KLKLKLKLKLKLKLKLKKLKKLKKLKKLKLLKLLKKLL,KLKLKLKLKLKLKLKLKKLKKLKKLKKLKLLKLLKKLL,L-T25,Free,Free,Branched,L,None,38,Antibacterial. Antibiofilm,MHC at 62.5 μg/ml,Human,Synthetic Peptide,PB and 20%TFE = α-Helical,NA,CTTHHHHTTSCCCSSCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11768,33532575,2021,klklklklklklklklkklkklkklkklkllkllkkll,K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}K{d}L{d}L{d}K{d}L{d}L{d}K{d}K{d}L{d}L{d},D-T25,Free,Free,Branched,D,None,38,Antibacterial. Antibiofilm,MHC at 125 μg/ml,Human,Synthetic Peptide,NA,NA,CCCTTHHHHHHHHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)O
11773,32812694,2021,FALGAVTKVLPKLFCLITRKC,FALGAVTKVLPKLFCLITRKC,Brevinin-1H,Free,Free,Linear,L,None,21,"Antibacterial, Antibiofilm, Antifungal",>20 % Hemolysis at 32 µM,Horse,Frog Amolops Hainanensis,Helix,NA,CCSTTTSCSSCCCCCCSSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11774,32812694,2021,FALGAVTKVLPKLFCLITRKC,FALGAVTKVLPKLFCLITRKC,Brevinin-1H,Free,Free,Linear,L,None,21,"Antibacterial, Antibiofilm, Antifungal",50 % Hemolysis at 53.12 µM,Horse,Frog Amolops Hainanensis,Helix,NA,CTTHHHHTTSCCCSSCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11775,32812694,2021,FALGAVTKVLPKLFCLITRKC,FALGAVTKVLPKLFCLITRKC,Brevinin-1H,Free,Free,Linear,L,None,21,"Antibacterial, Antibiofilm, Antifungal",9.49 % Hemolysis at 4 µM,Horse,Frog Amolops Hainanensis,Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11776,32812694,2021,FALGAVTCLIRTKCKVLPKLF,FALGAVTCLIRTKCKVLPKLF,Brevinin-1Ha,Free,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",22.1 % Hemolysis at 128 µM,Horse,Brevinin-1H Analogues,NA,NA,CTTHHHHHHHHHHHSSHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O
11777,32812694,2021,FALGAVTKVLYKLFCLITRKC,FALGAVTKVLYKLFCLITRKC,Brevinin-1HY,Free,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",28.48 % Hemolysis at 4 µM,Horse,Brevinin-1H Analogues,Helix,NA,CCSHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
11778,33141035,2021,RIIDLLWRVRRPQKPKFVTVWVR,RIIDLLWRVRRPQKPKFVTVWVR,PMAP-23,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",≤4 % Hemolysis at 1280 μg/ml,Mouse,Porcine Myeloid,two α-Helical,Non-hemolytic,CCHHHHHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C
11779,33141035,2021,RIIDRLWRVRRPQKPKFVIVWVR,RIIDRLWRVRRPQKPKFVIVWVR,PMAP-23R,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",≤4 % Hemolysis at 1280 μg/ml,Mouse,Pmap-23 Analogs,NA,Non-hemolytic,CCHHHHHHHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
11780,33141035,2021,RIIDRLWRVRRPQKPKFVIVWVR-K-Dec,RIIDRLWRVRRPQKPKFVIVWVR-K{ct:Dec},PMAP-23RI-Dec,Dec,Free,Linear,L,Dec = Decanoic acid,24,"Antibacterial, Antibiofilm",≤4 % Hemolysis at 1280 μg/ml,Mouse,Pmap-23 Analogs With Decanoic Acid,NA,Non-hemolytic,NA,NA
11868,34069651,2021,LKLLKKLL,LKLLKKLL{nt:α-(4-pentenyl)-Ala}{ct:Amid},Feleucin-K65,Amidation,α-(4-pentenyl)-Ala,Linear,L,α-(4-pentenyl)-Ala,9,"Antimicrobial, Antibiofilm",9.08 % Hemolysis at 64 μg/ml,Mouse,Feleucin-K3 Analogs (Frog Bombina Orientalis),50% TFE = α-Helical,NA,NA,NA
11869,34069651,2021,LKLLKKLL,LKLLKKLL{nt:α-(4-pentenyl)-Ala}{ct:Amid},Feleucin-K65,Amidation,α-(4-pentenyl)-Ala,Linear,L,α-(4-pentenyl)-Ala,9,"Antimicrobial, Antibiofilm",31.6 % Hemolysis at 128 μg/ml,Mouse,Feleucin-K3 Analogs (Frog Bombina Orientalis),50% TFE = α-Helical,NA,NA,NA
11870,34069651,2021,FLKLLKKLα-(4-pentenyl)-Ala,FLKLLKKL{nnr:α-(4-pentenyl)-Ala}{ct:Amid},Feleucin-K70,Amidation,Free,Linear,L,α-(4-pentenyl)-Ala,9,"Antimicrobial, Antibiofilm",1 % Hemolysis at 128 μg/ml,Mouse,Feleucin-K3 Analogs (Frog Bombina Orientalis),50% TFE = α-Helical,Non-hemolytic,NA,NA
11872,34073939,2021,GILGKLWEGVKSIF,GILGKLWEGVKSIF{ct:Amid},Hp1404,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilm",49.2 % Hemolysis at 50 µM,Mouse,Scorpion Heterometrus Petersii,"10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix",NA,CCCTTTTTTGGGTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
11875,34073939,2021,GILGKLWEGVKSIV,GILGKLWEGVKSIV{ct:Amid},Hp1404-V,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilm",0 % Hemolysis at 50 µM,Mouse,Hp404 Analogs,"10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix",Non-hemolytic,CCCHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)C(C)C
11876,34073939,2021,GILGKLWEGVKSIL,GILGKLWEGVKSIL{ct:Amid},Hp1404-L,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilm",45.8 % Hemolysis at 50 µM,Mouse,Hp404 Analogs,"10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix",NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C
11877,34073939,2021,GILGKLWEGVKSIL,GILGKLWEGVKSIL{ct:Amid},Hp1404-L,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilm",21.3 % Hemolysis at 25 µM,Mouse,Hp404 Analogs,"10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix",NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)C(C)C
11878,34073939,2021,GILGKLWEGVKSII,GILGKLWEGVKSII{ct:Amid},Hp1404-I,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilm",0 % Hemolysis at 25 µM,Mouse,Hp404 Analogs,"10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix",Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)O
11879,34073939,2021,GILGKLWEGVKSIW,GILGKLWEGVKSIW{ct:Amid},Hp1404-W,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilm",15.9 % Hemolysis at 50 µM,Mouse,Hp404 Analogs,"10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix",NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC)C(C)C
11880,34073939,2021,GILGKLWEGVKSIW,GILGKLWEGVKSIW{ct:Amid},Hp1404-W,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilm",1.7 % Hemolysis at 25 µM,Mouse,Hp404 Analogs,"10 mM SP buffer = Random coil, 30mM SDS and 50% TFE = α-Helix",Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)CC)C(C)C
11942,34220763,2021,WKKLKKLLKKLKKL,WKKLKKLLKKLKKL{nt:Acet}{ct:Amid},pepD2,Amidation,Acetylation,Linear,L,None,14,"Antibacterial, Antibiofilm",9.6 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
11943,34220763,2021,WKKLKKLLKKL,WKKLKKLLKKL{nt:Acet}{ct:Amid},pepD3,Amidation,Acetylation,Linear,L,None,14,"Antibacterial, Antibiofilm",3.15 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,PE/PG liposomes = α-Helical,Low hemolytic,CTTTHHHHHHHTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
11944,34220763,2021,WKKVKKVVKKVKKV,WKKVKKVVKKVKKV{nt:Acet}{ct:Amid},pepV2,Amidation,Acetylation,Linear,L,None,14,"Antibacterial, Antibiofilm",0.31 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Non-hemolytic,NA,CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)O
11945,34220763,2021,WKKIKKIIKKIKKI,WKKIKKIIKKIKKI{nt:Acet}{ct:Amid},pepI2,Amidation,Acetylation,Linear,L,None,14,"Antibacterial, Antibiofilm",0.27 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
11946,34220763,2021,WRRLRRLLRRLRRL,WRRLRRLLRRLRRL{nt:Acet}{ct:Amid},pepR2,Amidation,Acetylation,Linear,L,None,14,"Antibacterial, Antibiofilm",105.65 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
11947,34220763,2021,WOOLOOLLOOLOOL,W{nnr:O}{nnr:O}L{nnr:O}{nnr:O}LL{nnr:O}{nnr:O}L{nnr:O}{nnr:O}L{nt:Acet}{ct:Amid},pepO2,Amidation,Acetylation,Linear,L,O = L-Ornithine,14,"Antibacterial, Antibiofilm",0.23 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Non-hemolytic,NA,NA
11948,34220763,2021,Wkklkkllkklkkl,WK{d}K{d}L{d}K{d}K{d}L{d}L{d}K{d}K{d}L{d}K{d}K{d}L{d}{nt:Acet}{ct:Amid},pepdD2,Amidation,Acetylation,Linear,Mix,None,14,"Antibacterial, Antibiofilm",2.9 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)O
11949,34220763,2021,WKKLKKLLKKLKKL,WKKLKKLLKKLKKL{nt:Myr = myristyl}{ct:Amid},pepD2M,Amidation,Myr = myristyl,Linear,L,Myr = myristyl,14,"Antibacterial, Antibiofilm",93.63 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,CSCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
11950,34220763,2021,WKKLKKLLKKLKKL,WKKLKKLLKKLKKL{nt:Pal = palmitoyl}{ct:Amid},pepD2P,Amidation,Pal = palmitoyl,Linear,L,Pal = palmitoyl,14,"Antibacterial, Antibiofilm",83.45 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1)C(=O)O
11951,34220763,2021,WKKLKKLLKKLKKL,WKKLKKLLKKLKKL{nt:Ste = stearyl}{ct:Amid},pepD2S,Amidation,Ste = stearyl,Linear,L,Ste = stearyl,14,"Antibacterial, Antibiofilm",60.7 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)O
11952,34220763,2021,WKKLKKLLKKL,WKKLKKLLKKL{nt:Oct = octanoyl}{ct:Amid},pepD3O,Amidation,Oct = octanoyl,Linear,L,Oct = octanoyl,11,"Antibacterial, Antibiofilm",86.03 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,NA
11953,34220763,2021,WKKLKKLLKKL,WKKLKKLLKKL{nt:Hex = hexanoyl}{ct:Amid},pepD3H,Amidation,Hex = hexanoyl,Linear,L,Hex = hexanoyl,11,"Antibacterial, Antibiofilm",54.07 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,NA
11954,34220763,2021,WKKLKKLLKKL,WKKLKKLLKKL{nt:But = butanoyl}{ct:Amid},pepD3B,Amidation,But = butanoyl,Linear,L,But = butanoyl,11,"Antibacterial, Antibiofilm",7.89 % Hemolysis at 256 μg/ml,Rat,De Novo Designed Peptide,NA,Low hemolytic,NA,NA
11995,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",50 % Hemolysis at 886.5 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11996,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",0 % Hemolysis at 1 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11997,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",0 % Hemolysis at 2 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11998,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",0.4 % Hemolysis at 4 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11999,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",0.7 % Hemolysis at 8 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12000,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",1.4 % Hemolysis at 16 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12001,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",1.5 % Hemolysis at 32 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12002,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",1.8 % Hemolysis at 64 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12003,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",2.4 % Hemolysis at 128 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12004,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF,Kn2-5R,Free,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",10.6 % Hemolysis at 256 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,Low hemolytic,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12005,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",50 % Hemolysis at 16.77 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12006,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",0.1 % Hemolysis at 1 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12007,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",0.3 % Hemolysis at 2 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12008,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",2 % Hemolysis at 4 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12009,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",2.5 % Hemolysis at 8 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12010,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",5.4 % Hemolysis at 16 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12011,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",16.9 % Hemolysis at 32 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12012,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",40.3 % Hemolysis at 64 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12013,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",99.3 % Hemolysis at 128 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12014,34361810,2021,FIRRIARLLRRIF,FIRRIARLLRRIF{ct:Amid},Kn2-5R-NH2,Amidation,Free,Linear,L,None,13,"Anti-Salmonella, Antibiofilm",99.5 % Hemolysis at 256 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12015,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",50 % Hemolysis at 33.26 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12016,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",0 % Hemolysis at 1 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12017,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",0 % Hemolysis at 2 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12018,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",0.4 % Hemolysis at 4 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12019,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",0.5 % Hemolysis at 8 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12020,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",0.9 % Hemolysis at 16 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12021,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",2.5 % Hemolysis at 32 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12022,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",8.7 % Hemolysis at 64 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12023,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",23.6 % Hemolysis at 128 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12024,34361810,2021,firriarllrrif,F{d}I{d}R{d}R{d}I{d}A{d}R{d}L{d}L{d}R{d}R{d}I{d}F{d}{ct:Amid},dKn2-5R-NH2,Amidation,Free,Linear,D,None,13,"Anti-Salmonella, Antibiofilm",65.6 % Hemolysis at 256 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12025,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",50 % Hemolysis at 0.99 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12026,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",6.1 % Hemolysis at 1 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12027,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",15 % Hemolysis at 2 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12028,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",33.7 % Hemolysis at 4 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12029,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",61.6 % Hemolysis at 8 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12030,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",96.2 % Hemolysis at 16 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHHHHHHHHHHSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12031,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",97.6 % Hemolysis at 32 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHHHHHHHHHHSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12032,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",97.9 % Hemolysis at 64 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHHHHHHHHHHSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12033,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",99.8 % Hemolysis at 128 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHHHHHHHHHHSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12034,34361810,2021,FFFIRRIARLLRRIF,FFFIRRIARLLRRIF{ct:Amid},2F-Kn2-5R-NH2,Amidation,Free,Linear,L,None,15,"Anti-Salmonella, Antibiofilm",100 % Hemolysis at 256 µM,Sheep,Variants Of The Scorpion Venom Peptide Bmkn-2,α-Helix,NA,CHHHHHHHHHHHHHHHHHHHHSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12177,34028137,2021,VRLLRRRI,VRLLRRRI{nt:H}{ct:Amid},SAMP-A4,Amidation,H,Linear,L,None,8,"Antibacterial, Antifungal, Antibiofilm",5 % Hemolysis at 69.26 μg/ml,Human,Synthesized Antimicrobial Peptide A4,NA,Low hemolytic,CCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)O
12178,34028137,2021,VRLLRRRI,VRLLRRRI{nt:Acet}{ct:Amid},SAMP-A4-C2,Amidation,Acetylation,Linear,L,None,8,"Antibacterial, Antifungal, Antibiofilm",5 % Hemolysis at 34.56 μg/ml,Human,Samp-A4 Analogue,NA,Low hemolytic,CCCCCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)O
12179,34028137,2021,VRLLRRRI,VRLLRRRI{nt:Butyryl}{ct:Amid},SAMP-A4-C4,Amidation,Butyryl,Linear,L,None,8,"Antibacterial, Antifungal, Antibiofilm",5 % Hemolysis at 73.84 μg/ml,Human,Samp-A4 Analogue,NA,Low hemolytic,CCCTTHHHHHHHTGGGSSSSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)O
12180,34028137,2021,VRLLRRRI,VRLLRRRI{nt:Hexanoyl}{ct:Amid},SAMP-A4-C6,Amidation,Hexanoyl,Linear,L,None,8,"Antibacterial, Antifungal, Antibiofilm",5 % Hemolysis at 84.98 μg/ml,Human,Samp-A4 Analogue,NA,Low hemolytic,CTHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)O
12181,34028137,2021,VRLLRRRI,VRLLRRRI{nt:PEG}{ct:Amid},SAMP-A4-PEG3,Amidation,PEG,Linear,L,None,8,"Antibacterial, Antifungal, Antibiofilm",5 % Hemolysis at 19.95 μg/ml,Human,Samp-A4 Analogue,NA,Low hemolytic,CTHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)O
12182,34028137,2021,VRLLRRRI,VRLLRRRI{nt:Gluconyl}{ct:Amid},SAMP-A4-GlcA,Amidation,Gluconyl,Linear,L,None,8,"Antibacterial, Antifungal, Antibiofilm",5 % Hemolysis at 22.16 μg/ml,Human,Samp-A4 Analogue,NA,Low hemolytic,CHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)O
12223,34738013,2021,FIPLVSGLFSKLL,FIPLVSGLFSKLL{ct:Amid},Temporin-FL,Amidation,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",50 % Hemolysis at 157.4 µM,Horse,Frog Pelophylax Nigromaculatus,50%TFE/NH4Ac = Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
12224,34738013,2021,FIPLVSGLFKLL,FIPLVSGLFKLL{ct:Amid},Temporin-FLa,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",50 % Hemolysis at 74.02 µM,Horse,Temporin-Fl Truncated Analogues,50%TFE/NH4Ac = Helix,NA,CCCTHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
12225,34738013,2021,FIPVSGLFKLL,FIPVSGLFKLL{ct:Amid},Temporin-FLb,Amidation,Free,Linear,L,None,11,"Antimicrobial, Antibiofilm",50 % Hemolysis at 356 µM,Horse,Temporin-Fl Truncated Analogues,50%TFE/NH4Ac = Helix,Low hemolytic,CCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
12226,34819923,2021,WLRRIKAWLRRIKA,WLRRIKAWLRRIKA{ct:OH},RR4-OH,OH,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",3.2 ± 1.0 % Hemolysis at 150 µM,Horse,Short Synthetic Peptide,NA,Low hemolytic,CCCCCSSTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
12227,34819923,2021,WIRRIKKWIRRVHK,WIRRIKKWIRRVHK{ct:Amid},RR2-NH2,Amidation,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",13.0 ± 1.7 % Hemolysis at 150 µM,Horse,Short Synthetic Peptide,NA,NA,CCCCCSSTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
12228,34819923,2021,WLRRIKAWLRRKRK,WLRRIKAWLRRKRK{ct:Amid},RR3-NH2,Amidation,Free,Linear,L,None,15,"Antimicrobial, Antibiofilm",19.0 ± 3.3 % Hemolysis at 150 µM,Horse,Short Synthetic Peptide,NA,NA,CTTHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
12229,34819923,2021,WLRRIKAWLRRIKA,WLRRIKAWLRRIKA{ct:Amid},RR4-NH2,Amidation,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",64.3 ± 5.4 % Hemolysis at 150 µM,Horse,Short Synthetic Peptide,NA,NA,CCCCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
12230,34819923,2021,VFWRRIRVWVIR,VFWRRIRVWVIR{ct:Amid},LJK2,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",28.4 ± 1.9 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12231,34819923,2021,rivwvrirrwfv,R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid},RIJK2,Amidation,Free,Linear,D,None,12,"Antimicrobial, Antibiofilm",35.1 ± 8.3 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,CHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
12232,34819923,2021,RIVWVRIRRWFV,RIVWVRIRRWFV{ct:Amid},RJK2,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",19.2 ± 3.1 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,CHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
12233,34819923,2021,KRIVKLILKWLR,KRIVKLILKWLR{ct:Amid},KR-12-a5,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm, Anti-inflammatory",79.0 ± 0.6 % Hemolysis at 150 µM,Horse,Ll-37 Derivatives Synthetic Peptide,α-Helical,NA,CCTTTSSCHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12234,34819923,2021,WKKIRVRLSA,WKKIRVRLSA{ct:Amid},SB056,Amidation,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",1.7 ± 0.2 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCTTTCGGGHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)C(C)C
12235,34819923,2021,GILGKLWEGVKSIF,GILGKLWEGVKSIF{ct:Amid},HP1404,Amidation,Free,Linear,L,None,15,"Antimicrobial, Antibiofilm",100.0 ± 0.5 % Hemolysis at 150 µM,Horse,Scorpion Heterometrus Petersii,NA,NA,CCTTTCGGGHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
12236,34819923,2021,ILkKLlkkVKSI,ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid},HP1404 T1-D,Amidation,Free,Linear,Mix,None,12,"Antimicrobial, Antibiofilm",0.3 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CHHHHCSTHHHHGGGGTTTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12237,34819923,2021,ILkKLlkkVKki,ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid},HP1404 T1-E,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",0.8 ± 0.4 % Hemolysis at 150 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CCGGGSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12238,34819923,2021,FLFSLIPHAIGGLISAFK,FLFSLIPHAIGGLISAFK{ct:Amid},AamAP1,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.00 ± 1.3 % Hemolysis at 150 µM,Horse,Scorpion Venom Antimicrobial Peptide,NA,NA,CCCCCCSCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12239,34819923,2021,FLFSLIPKAIGGLISAFK,FLFSLIPKAIGGLISAFK{ct:Amid},AamAP-S1,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.00 ± 4.9 % Hemolysis at 150 µM,Horse,Aamap1 Analog,NA,NA,CCCCCCSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12240,34819923,2021,FLFSLIPRAIGGLISAFK,FLFSLIPRAIGGLISAFK{ct:Amid},AamAP-R,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.00 ± 4.3 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12241,34819923,2021,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid},Magainin 2,Amidation,Free,Linear,L,None,26,"Antimicrobial, Antibiofilm",35.2 ± 1.1 % Hemolysis at 150 µM,Horse,Synthetic Amp,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
12242,34819923,2021,GIGKFLHSAK,GIGKFLHSAK{ct:Amid},Magainin 2(1-10),Amidation,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",0.0 ± 0.4 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
12243,34819923,2021,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},Indolicidin,Amidation,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",95.1 ± 5.0 % Hemolysis at 150 µM,Horse,Synthetic Amp,NA,NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12244,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid},BP525,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",3.1 ± 1.0 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12245,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid},BP526,Amidation,C3H7CO,Linear,Mix,nter = C3H7CO,13,"Antimicrobial, Antibiofilm",8.3 ± 0.7 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCCSSCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12246,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid},BP527,Amidation,C5H11CO,Linear,Mix,nter = C5H11CO,13,"Antimicrobial, Antibiofilm",62.2 ± 4.4 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCSSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12247,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid},BP528,Amidation,C11H23CO,Linear,Mix,nter = C11H23CO,13,"Antimicrobial, Antibiofilm",92.1 ± 5.7 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12248,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid},BP529,Amidation,HOC11H22CO,Linear,Mix,nter = HOC11H22CO,13,"Antimicrobial, Antibiofilm",7.2 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCSSSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12249,34819923,2021,VRLIVAVRIWRR,VRLIVAVRIWRR{ct:Amid},IDR-1018,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",35.6 ± 4.4 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12250,34819923,2021,KRFRIRVRVIRK,KRFRIRVRVIRK{ct:Amid},HH15,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",2.3 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12251,34819923,2021,VQWRIRVRVIKK,VQWRIRVRVIKK{ct:Amid},1026,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",7.6 ± 0.8 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCCCGGGGGGTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12252,34819923,2021,KQFRIRVRV,KQFRIRVRV{ct:Amid},1029,Amidation,Free,Linear,L,None,9,"Antimicrobial, Antibiofilm",2.3 ± 0.7 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12253,34819923,2021,VQFRIRVRIVIRK,VQFRIRVRIVIRK{ct:Amid},1036,Amidation,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",6.5 ± 0.6 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CTTSGGGSGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C
12254,34819923,2021,KRFRIRVRV,KRFRIRVRV{ct:Amid},1037,Amidation,Free,Linear,L,None,9,"Antimicrobial, Antibiofilm",2.4 ± 0.4 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12255,34819923,2021,FRIRVRV,FRIRVRV{ct:Amid},FV7,Amidation,Free,Linear,L,None,7,"Antimicrobial, Antibiofilm",3.7 ± 0.4 % Hemolysis at 150 µM,Horse,Synthetic Peptide,α-Helical,Low hemolytic,CCCTHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12256,34819923,2021,RFRRLFRIRVRVLKKI,RFRRLFRIRVRVLKKI{ct:Amid},R-FV7-I16,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibiofilm",6.3 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic Peptide,α-Helical,Low hemolytic,CCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)O
12257,34819923,2021,WLRRIKAWLRRIKA-OH,WLRRIKAWLRRIKA-OH{ct:OH},RR4-OH,OH,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",9.8 ± 3.7 % Hemolysis at 250 µM,Horse,Short Synthetic Peptide,NA,Low hemolytic,NA,NA
12258,34819923,2021,WIRRIKKWIRRVHK,WIRRIKKWIRRVHK{ct:Amid},RR2-NH2,Amidation,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",14.0 ± 1.8 % Hemolysis at 250 µM,Horse,Short Synthetic Peptide,NA,NA,CCCCCSSTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
12259,34819923,2021,WLRRIKAWLRRKRK,WLRRIKAWLRRKRK{ct:Amid},RR3-NH2,Amidation,Free,Linear,L,None,15,"Antimicrobial, Antibiofilm",30.8 ± 4.2 % Hemolysis at 250 µM,Horse,Short Synthetic Peptide,NA,NA,CTTHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
12260,34819923,2021,WLRRIKAWLRRIKA,WLRRIKAWLRRIKA{ct:Amid},RR4-NH2,Amidation,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",85.0 ± 5.7 % Hemolysis at 250 µM,Horse,Short Synthetic Peptide,NA,NA,CCCCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
12261,34819923,2021,VFWRRIRVWVIR,VFWRRIRVWVIR{ct:Amid},LJK2,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",43.9 ± 3.7 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12262,34819923,2021,rivwvrirrwfv,R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid},RIJK2,Amidation,Free,Linear,D,None,12,"Antimicrobial, Antibiofilm",64.4 ± 9.4 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
12263,34819923,2021,RIVWVRIRRWFV,RIVWVRIRRWFV{ct:Amid},RJK2,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",29.6 ± 2.2 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
12264,34819923,2021,KRIVKLILKWLR,KRIVKLILKWLR{ct:Amid},KR-12-a5,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm, Anti-inflammatory",96.1 ± 1.8 % Hemolysis at 250 µM,Horse,Ll-37 Derivatives Synthetic Peptide,α-Helical,NA,CCTTTSSCHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12265,34819923,2021,WKKIRVRLSA,WKKIRVRLSA{ct:Amid},SB056,Amidation,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",1.8 ± 0.3 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,Non-hemolytic,CCTTTCGGGHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)C(C)C
12266,34819923,2021,GILGKLWEGVKSIF,GILGKLWEGVKSIF{ct:Amid},HP1404,Amidation,Free,Linear,L,None,15,"Antimicrobial, Antibiofilm",100.0 ± 3.9 % Hemolysis at 250 µM,Horse,Scorpion Heterometrus Petersii,NA,NA,CCTTTCGGGHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
12267,34819923,2021,ILkKLlkkVKSI,ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid},HP1404 T1-D,Amidation,Free,Linear,Mix,None,12,"Antimicrobial, Antibiofilm",0.8 ± 1.1 % Hemolysis at 250 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CHHHHCSTHHHHGGGGTTTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12268,34819923,2021,ILkKLlkkVKki,ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid},HP1404 T1-E,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",0.7 ± 0.4 % Hemolysis at 250 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CCGGGSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12269,34819923,2021,FLFSLIPHAIGGLISAFK,FLFSLIPHAIGGLISAFK{ct:Amid},AamAP1,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.0 ± 4.1 % Hemolysis at 250 µM,Horse,Scorpion Venom Antimicrobial Peptide,NA,NA,CCCCCCSCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12270,34819923,2021,FLFSLIPKAIGGLISAFK,FLFSLIPKAIGGLISAFK{ct:Amid},AamAP-S1,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.0 ± 2.1 % Hemolysis at 250 µM,Horse,Aamap1 Analog,NA,NA,CCCCCCSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12271,34819923,2021,FLFSLIPRAIGGLISAFK,FLFSLIPRAIGGLISAFK{ct:Amid},AamAP-R,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.0 ± 10.5 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12272,34819923,2021,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid},Magainin 2,Amidation,Free,Linear,L,None,26,"Antimicrobial, Antibiofilm",54.5 ± 3.7 % Hemolysis at 250 µM,Horse,Synthetic Amp,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
12273,34819923,2021,GIGKFLHSAK,GIGKFLHSAK{ct:Amid},Magainin 2(1-10),Amidation,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",0.0 ± 0.2 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
12274,34819923,2021,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},Indolicidin,Amidation,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",100.0 ± 4.4 % Hemolysis at 250 µM,Horse,Synthetic Amp,NA,NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12275,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid},BP525,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",3.8 ± 0.8 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12276,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid},BP526,Amidation,C3H7CO,Linear,Mix,nter = C3H7CO,13,"Antimicrobial, Antibiofilm",20.4 ± 0.7 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CCCCCSSCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12277,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid},BP527,Amidation,C5H11CO,Linear,Mix,nter = C5H11CO,13,"Antimicrobial, Antibiofilm",73.6 ± 1.1 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCSSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12278,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid},BP528,Amidation,C11H23CO,Linear,Mix,nter = C11H23CO,13,"Antimicrobial, Antibiofilm",96.6 ± 3.1 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12279,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid},BP529,Amidation,HOC11H22CO,Linear,Mix,nter = HOC11H22CO,13,"Antimicrobial, Antibiofilm",12.5 ± 0.6 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CCCCSSSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12280,34819923,2021,VRLIVAVRIWRR,VRLIVAVRIWRR{ct:Amid},IDR-1018,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",43.0 ± 0.2 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12281,34819923,2021,KRFRIRVRVIRK,KRFRIRVRVIRK{ct:Amid},HH15,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",4.5 ± 1.9 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12282,34819923,2021,VQWRIRVRVIKK,VQWRIRVRVIKK{ct:Amid},1026,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",10.8 ± 0.7 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCCCGGGGGGTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12283,34819923,2021,KQFRIRVRV,KQFRIRVRV{ct:Amid},1029,Amidation,Free,Linear,L,None,9,"Antimicrobial, Antibiofilm",3.5 ± 0.7 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12284,34819923,2021,VQFRIRVRIVIRK,VQFRIRVRIVIRK{ct:Amid},1036,Amidation,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",11.0 ± 1.6 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,NA,CTTSGGGSGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C
12285,34819923,2021,KRFRIRVRV,KRFRIRVRV{ct:Amid},1037,Amidation,Free,Linear,L,None,9,"Antimicrobial, Antibiofilm",3.3 ± 0.7 % Hemolysis at 250 µM,Horse,Synthetic Peptide,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12286,34819923,2021,FRIRVRV,FRIRVRV{ct:Amid},FV7,Amidation,Free,Linear,L,None,7,"Antimicrobial, Antibiofilm",4.4 ± 0.3 % Hemolysis at 250 µM,Horse,Synthetic Peptide,α-Helical,Low hemolytic,CCCTHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12287,34819923,2021,RFRRLFRIRVRVLKKI,RFRRLFRIRVRVLKKI{ct:Amid},R-FV7-I16,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibiofilm",8.0 ± 1.3 % Hemolysis at 250 µM,Horse,Synthetic Peptide,α-Helical,Low hemolytic,CCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)O
12288,34819923,2021,WLRRIKAWLRRIKA,WLRRIKAWLRRIKA{ct:OH},RR4-OH,OH,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",17.8 ± 0.3 % Hemolysis at 375 µM,Horse,Short Synthetic Peptide,NA,NA,CCCCCSSTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
12289,34819923,2021,WIRRIKKWIRRVHK,WIRRIKKWIRRVHK{ct:Amid},RR2-NH2,Amidation,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",17.9 ± 0.4 % Hemolysis at 375 µM,Horse,Short Synthetic Peptide,NA,NA,CCCCCSSTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
12290,34819923,2021,WLRRIKAWLRRKRK,WLRRIKAWLRRKRK{ct:Amid},RR3-NH2,Amidation,Free,Linear,L,None,15,"Antimicrobial, Antibiofilm",37.3 ± 4.4 % Hemolysis at 375 µM,Horse,Short Synthetic Peptide,NA,NA,CTTHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O
12291,34819923,2021,WLRRIKAWLRRIKA,WLRRIKAWLRRIKA{ct:Amid},RR4-NH2,Amidation,Free,Linear,L,None,14,"Antimicrobial, Antibiofilm",100.0 ± 5.4 % Hemolysis at 375 µM,Horse,Short Synthetic Peptide,NA,NA,CCCCSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O
12292,34819923,2021,VFWRRIRVWVIR,VFWRRIRVWVIR{ct:Amid},LJK2,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",72.4 ± 8.9 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12293,34819923,2021,rivwvrirrwfv,R{d}I{d}V{d}W{d}V{d}R{d}I{d}R{d}R{d}W{d}F{d}V{d}{ct:Amid},RIJK2,Amidation,Free,Linear,D,None,12,"Antimicrobial, Antibiofilm",71.0 ± 7.1 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
12294,34819923,2021,RIVWVRIRRWFV,RIVWVRIRRWFV{ct:Amid},RJK2,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",50.2 ± 5.4 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
12295,34819923,2021,KRIVKLILKWLR,KRIVKLILKWLR{ct:Amid},KR-12-a5,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm, Anti-inflammatory",100.0 ± 1.7 % Hemolysis at 375 µM,Horse,Ll-37 Derivatives Synthetic Peptide,α-Helical,NA,CCTTTSSCHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12296,34819923,2021,WKKIRVRLSA,WKKIRVRLSA{ct:Amid},SB056,Amidation,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",2.3 ± 0.7 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCTTTCGGGHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)O)C(C)C
12297,34819923,2021,GILGKLWEGVKSIF,GILGKLWEGVKSIF{ct:Amid},HP1404,Amidation,Free,Linear,L,None,15,"Antimicrobial, Antibiofilm",100.0 ± 0.7 % Hemolysis at 375 µM,Horse,Scorpion Heterometrus Petersii,NA,NA,CCTTTCGGGHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
12298,34819923,2021,ILkKLlkkVKSI,ILK{d}KLL{d}K{d}K{d}VKSI{ct:Amid},HP1404 T1-D,Amidation,Free,Linear,Mix,None,12,"Antimicrobial, Antibiofilm",1.3 ± 0.2 % Hemolysis at 375 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CHHHHCSTHHHHGGGGTTTTTC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12299,34819923,2021,ILkKLlkkVKki,ILK{d}KLL{d}K{d}K{d}VKK{d}I{d}{ct:Amid},HP1404 T1-E,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",1.5 ± 0.3 % Hemolysis at 375 µM,Horse,Synthetic Peptides,NA,Non-hemolytic,CCGGGSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)[C@@H](C)CC)C(C)C
12300,34819923,2021,FLFSLIPHAIGGLISAFK,FLFSLIPHAIGGLISAFK{ct:Amid},AamAP1,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.0 ± 4.4 % Hemolysis at 375 µM,Horse,Scorpion Venom Antimicrobial Peptide,NA,NA,CCCCCCSCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12301,34819923,2021,FLFSLIPKAIGGLISAFK,FLFSLIPKAIGGLISAFK{ct:Amid},AamAP-S1,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.0 ± 2.9 % Hemolysis at 375 µM,Horse,Aamap1 Analog,NA,NA,CCCCCCSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12302,34819923,2021,FLFSLIPRAIGGLISAFK,FLFSLIPRAIGGLISAFK{ct:Amid},AamAP-R,Amidation,Free,Linear,L,None,18,"Antimicrobial, Antibiofilm",100.0 ± 3.1 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
12303,34819923,2021,GIGKFLHSAKKFGKAFVGEIMNS,GIGKFLHSAKKFGKAFVGEIMNS{ct:Amid},Magainin 2,Amidation,Free,Linear,L,None,26,"Antimicrobial, Antibiofilm",71.1 ± 6.0 % Hemolysis at 375 µM,Horse,Synthetic Amp,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)CC)C(C)C
12304,34819923,2021,GIGKFLHSAK,GIGKFLHSAK{ct:Amid},Magainin 2(1-10),Amidation,Free,Linear,L,None,10,"Antimicrobial, Antibiofilm",0.0 ± 0.7 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O
12305,34819923,2021,ILPWKWPWWPWRR,ILPWKWPWWPWRR{ct:Amid},Indolicidin,Amidation,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",100.0 ± 2.5 % Hemolysis at 375 µM,Horse,Synthetic Amp,NA,NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12306,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{ct:Amid},BP525,Amidation,Free,Linear,Mix,None,13,"Antimicrobial, Antibiofilm",10.0 ± 5.9 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCCCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12307,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C3H7CO}{ct:Amid},BP526,Amidation,C3H7CO,Linear,Mix,nter = C3H7CO,13,"Antimicrobial, Antibiofilm",46.8 ± 3.3 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCCCSSCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12308,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C5H11CO}{ct:Amid},BP527,Amidation,C5H11CO,Linear,Mix,nter = C5H11CO,13,"Antimicrobial, Antibiofilm",100.0 ± 2.6 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCSSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12309,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:C11H23CO}{ct:Amid},BP528,Amidation,C11H23CO,Linear,Mix,nter = C11H23CO,13,"Antimicrobial, Antibiofilm",99.1 ± 8.0 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12310,34819923,2021,ILPfKfPffPfRR,ILPF{d}KF{d}PF{d}F{d}PF{d}RR{nt:HOC11H22CO}{ct:Amid},BP529,Amidation,HOC11H22CO,Linear,Mix,nter = HOC11H22CO,13,"Antimicrobial, Antibiofilm",39.0 ± 1.1 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCCSSSCCCCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12311,34819923,2021,VRLIVAVRIWRR,VRLIVAVRIWRR{ct:Amid},IDR-1018,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",45.9 ± 4.9 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12312,34819923,2021,KRFRIRVRVIRK,KRFRIRVRVIRK{ct:Amid},HH15,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",4.0 ± 0.4 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12313,34819923,2021,VQWRIRVRVIKK,VQWRIRVRVIKK{ct:Amid},1026,Amidation,Free,Linear,L,None,12,"Antimicrobial, Antibiofilm",14.5 ± 5.5 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCCCCGGGGGGTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
12314,34819923,2021,KQFRIRVRV,KQFRIRVRV{ct:Amid},1029,Amidation,Free,Linear,L,None,9,"Antimicrobial, Antibiofilm",3.4 ± 0.6 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCTTHHHHHTTTCHHHHHHSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12315,34819923,2021,VQFRIRVRIVIRK,VQFRIRVRIVIRK{ct:Amid},1036,Amidation,Free,Linear,L,None,13,"Antimicrobial, Antibiofilm",17.3 ± 1.3 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,NA,CCCHHHHHHHTTSSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C
12316,34819923,2021,KRFRIRVRV,KRFRIRVRV{ct:Amid},1037,Amidation,Free,Linear,L,None,9,"Antimicrobial, Antibiofilm",4.9 ± 0.2 % Hemolysis at 375 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCSSHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12317,34819923,2021,FRIRVRV,FRIRVRV{ct:Amid},FV7,Amidation,Free,Linear,L,None,7,"Antimicrobial, Antibiofilm",9.5 ± 1.4 % Hemolysis at 375 µM,Horse,Synthetic Peptide,α-Helical,Low hemolytic,CTHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
12318,34819923,2021,RFRRLFRIRVRVLKKI,RFRRLFRIRVRVLKKI{ct:Amid},R-FV7-I16,Amidation,Free,Linear,L,None,16,"Antimicrobial, Antibiofilm",9.7 ± 0.6 % Hemolysis at 375 µM,Horse,Synthetic Peptide,α-Helical,Low hemolytic,CTHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(C)C)C(C)C)C(=O)O
12319,34508563,2021,FLGALFKVASKLVPAAICSISKKC,FLGALFKVASKLVPAAICSISKKC,Brevinin-1HL,Free,Free,Linear,L,None,24,"Antimicrobial, Anticancer, Antibiofilm",50 % Hemolysis at 11.5 ± 0.2 µM,Horse,"Broad-Folded Frog, Hylarana Latouchii","aqueous = Random coil, 50% TFE = α-Helical",NA,CTHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC
12320,34508563,2021,FFPLIFGALSSILPKIL,FFPLIFGALSSILPKIL,Temporin-HLa,Free,Free,Linear,L,None,17,"Antimicrobial, Anticancer, Antibiofilm",50 % Hemolysis at 31.4 ± 0.7 µM,Horse,"Broad-Folded Frog, Hylarana Latouchii","aqueous = Random coil, 50% TFE = α-Helical",NA,CTHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
12321,34508563,2021,FLQHIIGALSHIF,FLQHIIGALSHIF,Temporin-HLb,Free,Free,Linear,L,None,13,"Antimicrobial, Anticancer, Antibiofilm",50 % Hemolysis at 18.6 ± 10.0 mM,Horse,"Broad-Folded Frog, Hylarana Latouchii","aqueous = Random coil, 50% TFE = α-Helical",Low hemolytic,CTHHHHHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12358,34959645,2021,SKEKIGKEFKRIVQRIKDFLRNLV,SKEKIGKEFKRIVQRIKDFLRNLV{ct:Amid},SK-24,Amidation,Free,Linear,L,None,24,"Antibacterial, Antibiofilm",<25 % Hemolysis at 200 µM,Human,Ll-37 Derived Peptide,"PBS, 60mMSDS = Helical",Low hemolytic,CTHHHHHHHHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12359,34959645,2021,GIKEFKRIVQRIKDFLRNLV,GIKEFKRIVQRIKDFLRNLV{ct:Amid},GI-20,Amidation,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",50 % Hemolysis at ~160 µM,Human,Ll-37 Derived Peptide,"PBS, 60mMSDS = Helical",NA,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12360,34959645,2021,GFKRIVQRIKDFLRNLV,GFKRIVQRIKDFLRNLV{ct:Amid},GF-17,Amidation,Free,Linear,L,None,17,"Antibacterial, Antibiofilm",50 % Hemolysis at 175 µM,Human,Ll-37 Derived Peptide,"PBS, 60mMSDS = Helical",NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)CN)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)C(C)C
12361,34959645,2021,GXKRlVQRlKDXLRNLV,G{nnr:X}KRlVQRlKD{nnr:X}LRNLV{ct:Amid},17BIPHE2,Amidation,Free,Linear,Mix,X = biphenylalanines,17,"Antibacterial, Antibiofilm",50 % Hemolysis at ~200 µM,Human,Ll-37 Derived Peptide,"PBS = distorted, 60mMSDS = Helical",NA,NA,NA
12418,34908502,2021,GMFTNMLKGIGKLAGKAALGAVKTLA,GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid},Dermaseptin-AC,Amidation,Free,Linear,L,None,26,"Antibacterial, Antibiofilm",50 % Hemolysis at 76.55 µM,Horse,Frog Agalychnis Callidryas,50% TFE-10 mM NH4Ac solution = α-Helix,NA,CCSSCSCTTTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
12419,34908502,2021,GMFTNMLKGIGKLAGKAALGAVKTLA,GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid},Dermaseptin-AC,Amidation,Free,Linear,L,None,26,"Antibacterial, Antibiofilm",2.73 % Hemolysis at 2 µM,Horse,Frog Agalychnis Callidryas,50% TFE-10 mM NH4Ac solution = α-Helix,NA,CCGGGCTTCSSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
12420,34908502,2021,GMFTNMLKGIGKLAGKAALGAVKTLA,GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid},Dermaseptin-AC,Amidation,Free,Linear,L,None,26,"Antibacterial, Antibiofilm",4.31 % Hemolysis at 4 µM,Horse,Frog Agalychnis Callidryas,50% TFE-10 mM NH4Ac solution = α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
12421,34908502,2021,GMFTNMLKGIGKLAGKAALGAVKTLA,GMFTNMLKGIGKLAGKAALGAVKTLA{ct:Amid},Dermaseptin-AC,Amidation,Free,Linear,L,None,26,"Antibacterial, Antibiofilm",7.47 % Hemolysis at 8 µM,Horse,Frog Agalychnis Callidryas,50% TFE-10 mM NH4Ac solution = α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C
12427,34825276,2022,INWL-Dap-LG-Dap-MVIDAL,INWL-{nnr:Dap}-LG-{nnr:Dap}-MVIDAL{ct:Amid},PMPII,Amidation,Free,Linear,L,"Dap = L-2,3-Diamino-propionic",14,"Antibacterial, Antifungal, Antibiofilm",0 % Hemolysis at 256 µM,Mouse,Mpii Analogs,"10 mM PBS, pH 7.4 = unordered, 50% TFE in PBS = Helical",Non-hemolytic,NA,NA
12439,35145500,2022,RRLFRRILRWL,RRLFRRILRWL{ct:Amid},RW-BP-100,Amidation,Free,Linear,L,None,11,"Antibacterial, Antifungal, Antibiofilm",3.10 ± 0.77 % Hemolysis at 50 μg/ml,Sheep,Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12443,35145500,2022,RRLfRRILRWL,RRLF{d}RRILRWL{ct:Amid},RW-BP100-4D*,Amidation,Free,Linear,Mix,None,11,"Antibacterial, Antifungal, Antibiofilm",0.11 ± 0.19 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12453,35145500,2022,RRLFRRILRWL,RRLFRRILRWL{ct:Amid},RW-BP-100,Amidation,Free,Linear,L,None,11,"Antibacterial, Antifungal, Antibiofilm",4.70 ± 0.49 % Hemolysis at 100 μg/ml,Sheep,Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12457,35145500,2022,RRLfRRILRWL,RRLF{d}RRILRWL{ct:Amid},RW-BP100-4D*,Amidation,Free,Linear,Mix,None,11,"Antibacterial, Antifungal, Antibiofilm",3.69 ± 0.01 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12467,35145500,2022,RRLFRRILRWL,RRLFRRILRWL{ct:Amid},RW-BP-100,Amidation,Free,Linear,L,None,11,"Antibacterial, Antifungal, Antibiofilm",41.82 ± 2.27 % Hemolysis at 150 μg/ml,Sheep,Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12471,35145500,2022,RRLfRRILRWL,RRLF{d}RRILRWL{ct:Amid},RW-BP100-4D*,Amidation,Free,Linear,Mix,None,11,"Antibacterial, Antifungal, Antibiofilm",18.75 ± 0.42 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12481,35145500,2022,RRLFRRILRWL,RRLFRRILRWL{ct:Amid},RW-BP-100,Amidation,Free,Linear,L,None,11,"Antibacterial, Antifungal, Antibiofilm",56.67 ± 6.33 % Hemolysis at 300 μg/ml,Sheep,Bp100 (Hybrid Of Cecropin A And Melittin M) Analogues,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12485,35145500,2022,RRLfRRILRWL,RRLF{d}RRILRWL{ct:Amid},RW-BP100-4D*,Amidation,Free,Linear,Mix,None,11,"Antibacterial, Antifungal, Antibiofilm",48.55 ± 2.53 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12495,34506798,2022,VWLSALKFIGKHLAKHQLSKL,VWLSALKFIGKHLAKHQLSKL{ct:Amid},Lycosin-II,Amidation,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",1 % Hemolysis at 2 µM,Sheep,Venom Of The Spider Lycosa Singoriensis,30 mM SDS and 50% TFE = α-Helical,Low hemolytic,CTTHHHHHHHHHHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
12496,34506798,2022,VWLSALKFIGKHLAKHQLSKL,VWLSALKFIGKHLAKHQLSKL{ct:Amid},Lycosin-II,Amidation,Free,Linear,L,None,21,"Antibacterial, Antibiofilm",<5 % Hemolysis at 16 µM,Sheep,Venom Of The Spider Lycosa Singoriensis,30 mM SDS and 50% TFE = α-Helical,Low hemolytic,CTTHHHHHHHHHHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
12500,35792128,2022,GLKSLGRKILRAWRKAVRIVQRI,GLKSLGRKILRAWRKAVRIVQRI,MAA-41,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",0.6 % Hemolysis at 5 µM,Human,Hybrid Of (Bamp-28/Ll37),α-Helical,NA,CTTHHHHHHHHHHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
12501,35792128,2022,GLKSLGRKILRAWRKAVRIVQRI,GLKSLGRKILRAWRKAVRIVQRI,MAA-41,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",0.8 % Hemolysis at 10 µM,Human,Hybrid Of (Bamp-28/Ll37),α-Helical,NA,CTTHHHHHHHHHHHHHGGGGTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
12502,35792128,2022,GLKSLGRKILRAWRKAVRIVQRI,GLKSLGRKILRAWRKAVRIVQRI,MAA-41,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",2.5 % Hemolysis at 20 µM,Human,Hybrid Of (Bamp-28/Ll37),α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
12503,35792128,2022,GLKSLGRKILRAWRKAVRIVQRI,GLKSLGRKILRAWRKAVRIVQRI,MAA-41,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",8.7 % Hemolysis at 40 µM,Human,Hybrid Of (Bamp-28/Ll37),α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
12504,35792128,2022,GLKSLGRKILRAWRKAVRIVQRI,GLKSLGRKILRAWRKAVRIVQRI,MAA-41,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",10.1 % Hemolysis at 60 µM,Human,Hybrid Of (Bamp-28/Ll37),α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
12505,35792128,2022,GLKSLGRKILRAWRKAVRIVQRI,GLKSLGRKILRAWRKAVRIVQRI,MAA-41,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",14.8 % Hemolysis at 80 µM,Human,Hybrid Of (Bamp-28/Ll37),α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
12506,35792128,2022,GLKSLGRKILRAWRKAVRIVQRI,GLKSLGRKILRAWRKAVRIVQRI,MAA-41,Free,Free,Linear,L,None,23,"Antibacterial, Antibiofilm",37.2 % Hemolysis at 100 µM,Human,Hybrid Of (Bamp-28/Ll37),α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(C)C)C(=O)O
12545,36465844,2022,GVKFAKRFWRFAKKAFKRFEK,GVKFAKRFWRFAKKAFKRFEK{nt:Amid},HAZ,Free,Amidation,Linear,L,None,21,"Antibacterial, Antibiofilm, Anticancer",20 % Hemolysis at 120 µM,Human,Synthetic Hybride (Palustrin-1D And Hp(2–20)) Peptide,α-Helical,NA,CTTCCCSSTTCGGGGHHHHHHHC,CC(C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O
12546,36350889,2022,GRKSAKIGKRAKRIVQRIKDFLR,GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid},LL37-1,Amidation,Free,Linear,L,None,23,Antibiofilm,≤5 % Hemolysis at 1.5 µM,Human,Ll37 Analogous,α-Helical,NA,CCSHHHHHHHHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12549,36350889,2022,GRKSAKIGKRAKRIVQRIKDfLR,GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid},DLL37-1,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acid,23,"Antibacterial, Antibiofilm",≤5 % Hemolysis at 1.5 µM,Human,Ll37 Analogous,α-Helical,NA,CTTCCCSSTTCGGGGHHHHHHHC,NA
12550,36350889,2022,GRKSAKIGKRAKRIVQRIKDFLR,GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid},LL37-1,Amidation,Free,Linear,L,None,23,Antibiofilm,≤5 % Hemolysis at 2.5 µM,Human,Ll37 Analogous,α-Helical,NA,CCSHHHHHHHHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12553,36350889,2022,GRKSAKIGKRAKRIVQRIKDfLR,GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid},DLL37-1,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acid,23,"Antibacterial, Antibiofilm",≤5 % Hemolysis at 2.5 µM,Human,Ll37 Analogous,α-Helical,NA,CTTCCCSSTTCGGGGHHHHHHHC,NA
12554,36350889,2022,GRKSAKIGKRAKRIVQRIKDFLR,GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid},LL37-1,Amidation,Free,Linear,L,None,23,Antibiofilm,≤5 % Hemolysis at 5 µM,Human,Ll37 Analogous,α-Helical,NA,CCSHHHHHHHHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12557,36350889,2022,GRKSAKIGKRAKRIVQRIKDfLR,GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid},DLL37-1,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acid,23,"Antibacterial, Antibiofilm",≤5 % Hemolysis at 5 µM,Human,Ll37 Analogous,α-Helical,NA,CHHHHGGGTC,NA
12558,36350889,2022,GRKSAKIGKRAKRIVQRIKDFLR,GRKSAKIGKRAKRIVQRIKDFLR{ct:Amid},LL37-1,Amidation,Free,Linear,L,None,23,Antibiofilm,≤20 % Hemolysis at 10 µM,Human,Ll37 Analogous,α-Helical,NA,CTHHHHGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)CC
12561,36350889,2022,GRKSAKIGKRAKRIVQRIKDfLR,GRKSAKIGKRAKRIVQRIKDF{d}LR{nt:Acet}{ct:Amid},DLL37-1,Amidation,Acetylation,Linear,Mix,lowercase letters correspond to D-amino acid,23,"Antibacterial, Antibiofilm",≤20 % Hemolysis at 10 µM,Human,Ll37 Analogous,α-Helical,NA,CTHHHHTTTC,NA
12605,36432731,2022,TGLGKIGYLMKKLLSKAKV,TGLGKIGYLMKKLLSKAKV,LS-AMP-F1,Free,Free,Linear,L,None,19,"Antibacterial, Antibiofilm",17 % Hemolysis at 200 µM,Mouse,Spider Lycosa Sinensis,α-Helical,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C
12606,36432731,2022,AGMKNIIDAIKKKLGGKL,AGMKNIIDAIKKKLGGKL,LS-AMP-E1,Free,Free,Linear,L,None,18,"Antibacterial, Antibiofilm",<37.5 % Hemolysis at 200 µM,Mouse,Spider Lycosa Sinensis,α-Helical,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
12665,36547631,2022,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,defensin-like protein 1 (D-lp1),Free,Free,Linear,L,None,47,"Antifungal, Antibiofilm, Anti-virulence, Anti-Candida",0.48 % Hemolysis at 0.19 mg/mL,Horse,Sulphur-Rich Defensin Present In Barley Endosperm,NA,Low hemolytic,CCCGGGTCSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
12666,36547631,2022,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,defensin-like protein 1 (D-lp1),Free,Free,Linear,L,None,47,"Antifungal, Antibiofilm, Anti-virulence, Anti-Candida",1.74 % Hemolysis at 0.39 mg/mL,Horse,Sulphur-Rich Defensin Present In Barley Endosperm,NA,Low hemolytic,CCCGGGTCSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
12667,36547631,2022,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,defensin-like protein 1 (D-lp1),Free,Free,Linear,L,None,47,"Antifungal, Antibiofilm, Anti-virulence, Anti-Candida",9.55 % Hemolysis at 0.78 mg/mL,Horse,Sulphur-Rich Defensin Present In Barley Endosperm,NA,Low hemolytic,CCCGGGTCSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
12668,36547631,2022,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,RICRRRSAGFKGPCVSNKNCAQVCMQEGWGGGNCDGPLRRCKCMRRC,defensin-like protein 1 (D-lp1),Free,Free,Linear,L,None,47,"Antifungal, Antibiofilm, Anti-virulence, Anti-Candida",14.72 % Hemolysis at 1.56 mg/mL,Horse,Sulphur-Rich Defensin Present In Barley Endosperm,NA,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
12692,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 5 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CCTTTTTTTHHHHGGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12693,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 10 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CCTTTTTTTHHHHGGGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12694,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 20 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CTHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12695,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 40 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CTHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12696,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 60 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CTHHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12697,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 80 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CCGGGCSSHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12698,36321228,2023,LFDKIEKVFKRFRKKFKKLF,LFDKIEKVFKRFRKKFKKLF,SK4,Free,Free,Linear,L,None,20,"Antibacterial, Antibiofilm",0 % Hemolysis at 100 µM,Horse,Hybrid Peptide Resulting From Cecropin A And Bmap-27,α-Helical,Non-hemolytic,CCGGGCSSHHHHHTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C
12699,36668862,2023,LLKKVLALLKKVL,LLKKVLALLKKVL{nt:Amid},Hp-MAP3,Free,Amidation,Linear,L,None,13,"Antibacterial, Antibiofilm, Antifungal, Anticancer",~15 % Hemolysis at 10.8 µM,mouse,Temporin-Pta Analog,50% TFE or SDS = α-Helix,NA,CCCCCSGGGTTTCCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(=O)O
12700,36668862,2023,LLKKVLALLKKVL,LLKKVLALLKKVL{nt:Amid},Hp-MAP3,Free,Amidation,Linear,L,None,13,"Antibacterial, Antibiofilm, Antifungal, Anticancer",25 % Hemolysis at 21.6 µM,mouse,Temporin-Pta Analog,50% TFE or SDS = α-Helix,NA,CCSSCCCTTTTTTCCTTSSSTTSBSSSBC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(=O)O
12701,36668862,2023,LLKKVLALLKKVL,LLKKVLALLKKVL{nt:Amid},Hp-MAP3,Free,Amidation,Linear,L,None,13,"Antibacterial, Antibiofilm, Antifungal, Anticancer",~85 % Hemolysis at 43.3 µM,mouse,Temporin-Pta Analog,50% TFE or SDS = α-Helix,NA,CCSGGGGGHHHHHHHTTCCC,CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(C)C)C(C)C)C(=O)O
12770,37242633,2023,VRLIVAVRIWRR,VRLIVAVRIWRR{ct:Amid},IDR1018,Amidation,Free,Linear,L,None,12,"Wound healing, Antibiofilm, Antibacterial",20 % Hemolysis at 128 μg/ml,Human,Cationic Host Defense Peptides,NA,NA,CBTTBCSTTCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12771,37242633,2023,VRLIVAVRIWRR,VRLIVAVRIWRR{nt:PEG6}{ct:Amid},PEG6-IDR1018,Amidation,PEG6,Linear,L,None,12,"Wound healing, Antibiofilm, Antibacterial",0 % Hemolysis at 128 μg/ml,Human,Cationic Host Defense Peptides,NA,Non-hemolytic,CCSSSSCSCSCTTTTSSSSCSCCSSCSSSSSSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12772,37242633,2023,T(GlcNAc)VRLIVAVRIWRR,T{nnr:GlcNAc}VRLIVAVRIWRR{ct:Amid},Glc-IDR1018,Amidation,Free,Linear,L,GlcNAc = N-acetyl glucosamine,13,"Wound healing, Antibiofilm, Antibacterial",0 % Hemolysis at 128 μg/ml,Human,Cationic Host Defense Peptides,NA,Non-hemolytic,NA,NA
12773,36951612,2023,AKAFLPIIRWKKRW,AKAFLPIIRWKKRW{nt:C8H15O}{ct:C6H12NO5},GLP6,C6H12NO5,C8H15O,Linear,L,None,14,"Antibacterial, Antibiofilm",5.15 % Hemolysis at 8 µM,mouse,Synthetic Glycosylated Lp6 Lipopeptide,"SDS = 67.5% α-Helical, pure water =7 .38% α-Helical",NA,CCTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12774,36951612,2023,AKAFLPIIRWKKRW,AKAFLPIIRWKKRW{nt:C8H15O}{ct:C6H12NO5},GLP6,C6H12NO5,C8H15O,Linear,L,None,14,"Antibacterial, Antibiofilm",15.6 % Hemolysis at 16 µM,mouse,Synthetic Glycosylated Lp6 Lipopeptide,"SDS = 67.5% α-Helical, pure water =7 .38% α-Helical",NA,CCTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12775,36951612,2023,AKAFLPIIRWKKRW,AKAFLPIIRWKKRW{nt:C8H15O}{ct:C6H12NO5},GLP6,C6H12NO5,C8H15O,Linear,L,None,14,"Antibacterial, Antibiofilm",60.67 % Hemolysis at 64 µM,mouse,Synthetic Glycosylated Lp6 Lipopeptide,"SDS = 67.5% α-Helical, pure water =7 .38% α-Helical",NA,CCTTHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12796,37140456,2023,VRVGPCDQVCSRTNPEKDECCRAHGHSGHSSCYGGRMNCYG,VRVGPCDQVCSRTNPEKDECCRAHGHSGHSSCYGGRMNCYG,blapstin,Free,Free,Linear,L,None,41,"Antibiofilm, Antifungal",50 % Hemolysis at >112.5 µM,Human,Beetle Blaps Rhynchopetera,"Random curl (34.80%), β-Turns (22.54%), β-Sheet (20.66%), α-Helix (5.22%)",NA,CCCCSSSSCCCSSSCCCSSCSCCSSSCC,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O
12803,37300579,2023,HIDWKKLLDAAKQIL,HIDWKKLLDAAKQIL{ct:Amid},MP1,Amidation,Free,Linear,L,None,15,"Antibacterial, Antibiofilm, Antifungal",50 % Hemolysis at 221.4 µM,Human,Mastoparan Family,α-Helix,Low hemolytic,CCCCCCCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
12804,37300579,2023,HIDWKKLLDAAKKIL,HIDWKKLLDAAKKIL{ct:Amid},MP1-Q12K,Amidation,Free,Linear,L,None,15,"Antibacterial, Antibiofilm, Antifungal",50 % Hemolysis at 187.4 µM,Human,Mp1 Analog,α-Helix,Low hemolytic,CCCCCCCCTTCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
12824,37686259,2023,RKYKEKKDKSQNKKKKRKCMIL,RKYKEKKDKSQNKKKKRKCMIL,RK22,Free,Free,Linear,L,None,22,"Antibacterial, Antibiofilm",0 % Hemolysis at 400 μg/ml,Mouse,Leech Hirudinaria Manillensis,NA,Non-hemolytic,CCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)O
12826,36508953,2023,PFKLSLHL,PFKLSLHL{ct:Amid},Jelleine-I,Amidation,Free,Linear,L,None,8,"Antibacterial, Antibiofilm, Anti-Listeria monocytogenes",26.25 % Hemolysis at 1000 μg/ml,Rabbit,Honeybees Royal Jelly,NA,Low hemolytic,CGGGGTHHHHTTTCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(=O)O
12842,36870201,2023,FVQWFSKFLGRIL,FVQWFSKFLGRIL{ct:Amid},Temporin L,Amidation,Free,Linear,L,None,13,"Antibacterial, Antibiofilm",50 % Hemolysis at 15 µM,Human,European Frog Rana Temporaria,"PC/PG (3:1 w/w) = 70.1% Helical, PC/Chol (8:1 w/w) vesicles = 61.7% Helical",NA,CCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
12843,36870201,2023,FVQWFSKF(βL)RIL,FVQWFSKF{nnr:βL}RIL{ct:Amid},L9βl-TL,Amidation,Free,Linear,L,βL = βL,12,"Antibacterial, Antibiofilm",50 % Hemolysis at 33.3 µM,Human,Tl-Analogue,"PC/PG (3:1 w/w) = 13.8% Helical, PC/Chol (8:1 w/w) vesicles = 7.2% Helical",NA,NA,NA
12848,37167720,2023,RRWQWRpPRWQWRR,RRWQWRP{d}PRWQWRR{ct:Amid},Lf6-pP,Amidation,Free,Linear,L,p = D-Proline,14,"Antibacterial, Antibiofilm, Anti-inflammatory",10 % Hemolysis at >512 µM,Sheep,Synthetic Amps,"Phosphate buffer and 50% TFE = typical TrpZip Hairpin, 30 mM SDS = α-Helical",Low hemolytic,CHHHHHHHHHHTC,NA
12849,37167720,2023,RRWQWRGGRWQWRR,RRWQWRGGRWQWRR{ct:Amid},Lf6-GG,Amidation,Free,Linear,L,None,14,"Antibacterial, Antibiofilm",10 % Hemolysis at >512 µM,Sheep,Synthetic Amps,"Phosphate buffer and 50% TFE = typical TrpZip Hairpin, 30 mM SDS = α-Helical",Low hemolytic,CCHHHHHHHTC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
12950,35282007,2022,SMATPHAGAAALILSKHPTWTNAQVRDRLESTATYLGNSFYYGK,SMATPHAGAAALILSKHPTWTNAQVRDRLESTATYLGNSFYYGK,Natto peptide,Free,Free,Linear,L,None,45,"Cytotoxicity, Antimicrobial, Antibiofilm",<1.8 % Hemolysis at 200 μg/ml,Rabbit,Soybeans,NA,Non-hemolytic,CCCHHHHHSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O
13852,20451254,2010,FLSLIPHIVSGVASIAKHF,FLSLIPHIVSGVASIAKHF{ct:Amid},Phylloseptin-1 (PSN-1),Amidation,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Antiparasitic, Hemolytic, Antibiofilm",6.7 % Hemolytic at 5 µM,Horse,"The Waxy Monkey Frog, Phyllomedusa Sauvagei, South America",Helix,NA,CCCCCCCSSCSCCSSSSSCBSSTTCBSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
13911,30802593,2019,FIVPSIFLLKKAFCIALKKC,FIVPSIFLLKKAFCIALKKC,Japonicin-2LF,Free,Free,Linear,L,None,20,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic, Antibiofilm",>80 % Hemolytic at 64 µM,Horse,"Fujian Large-Headed Frog Skin Secretion, Limnonectes Fujianensis, China, Asia",Helix,NA,CHHHHHHHHTHHHHHHHHHHHCCCSSCCGGGGSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13917,37228702,2023,FLPLLAGLAANFLPQIICKIARKC,FLPLLAGLAANFLPQIICKIARKC,Brevinin-1-AW,Free,Free,Linear,L,None,24,"Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm, Anticance",50 % Hemolytic at 23.96 µM,Horse,"Skin Secretion, The Wuyi Torrent Frog, Amolops Wuyiensis, China, Asia",Helix,NA,CCGGGGHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13918,37228702,2023,FLPLLAGLAANFLPKIICKIARKC,FLPLLAGLAANFLPKIICKIARKC,B1AW-K,Free,Free,Linear,L,None,24,"Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm, Anticance",50 % Hemolytic at 10.6 µM,Horse,Synthetic Peptide,Helix,NA,CGGGSCTTHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13946,38074470,2023,FLGTVLKVAAKVLPAALCQIFKKC,FLGTVLKVAAKVLPAALCQIFKKC,Brevinin-1LTe,Free,Free,Linear,L,None,24,"Antibacterial, Anti-MRSA, Hemolytic, Antibiofilm",50 % Hemolytic at 6.4 µM,Human,"Skin Secretion, The Broad-Folded Frog, Hylarana Latouchii",NA,NA,CHHHHHHHGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13947,38360076,2024,KWIRRIIRDYKKFFIKFII,KWIRRIIRDYKKFFIKFII,KWI-19,Free,Free,Linear,L,None,19,"Antifungal, Hemolytic, Antibiofilm",50 % Hemolytic at 10 µM,Human,Synthetic Peptide,Helix,NA,CGGGHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
13948,38611812,2024,FLPLLAGLAASFLPTIFCKISRKC,FLPLLAGLAASFLPTIFCKISRKC{cyc:18-24},Brevinin-1BW,C-terminus contains a Rana box: one disulfide bond.,Free,Linear,L,None,24,"Antibacterial, Anti-inflammatory, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 35.8 μg/ml,Sheep,"Skin, Pelophylax Nigromaculatus, East Asia",NA,NA,CCCCTHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
13951,36138742,2022,FLKIIGKLLSGLL,FLKIIGKLLSGLL,VM-3K,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Hemolytic, Antibiofilm",50 % Hemolytic at 11.2 µM,Horse,Synthetic Peptide,Helix,NA,CCTHHHHHHHHHHHHHHHHHSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13952,36138742,2022,FLGIIGKLLSGLL,FLGIIGKLLSGLL,VM-3G,Free,Free,Linear,L,None,13,"Antibacterial Gram+, Anti-MRSA, Hemolytic, Antibiofilm",50 % Hemolytic at 9.7 µM,Horse,Synthetic Peptide,Helix,NA,CCCCHHHHHHHHHHHHHTTTSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13953,36138742,2022,FLWIIGKLLSGLL,FLWIIGKLLSGLL,VM-3W,Free,Free,Linear,L,None,13,"Antibacterial Gram+, Anti-MRSA, Hemolytic, Antibiofilm",50 % Hemolytic at 9.7 µM,Horse,Synthetic Peptide,Helix,NA,CTHHHHHHHHGGGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
13965,39204443,2024,FLSLIPHAISAVSALAKHL,FLSLIPHAISAVSALAKHL,Phylloseptin-TO2,Free,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 64 µM,Horse,"Skin Secretion, Super Tiger Leg Monkey Tree Frog, Phyllomedusa Tomopterna, Central America, South America",Helix,NA,CCCCGGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13966,39204443,2024,FLSLIPKAISAVSALAKHL,FLSLIPKAISAVSALAKHL,PSTO2 7K,Free,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 32-64 µM,Horse,Synthetic Peptide,Helix,NA,CCHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13967,39204443,2024,FLSLIPKAISAVSALAKKL,FLSLIPKAISAVSALAKKL,PSTO2 18K,Free,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 64 µM,Horse,Synthetic Peptide,Helix,NA,CCCCCSCHHHHHHHHCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13968,39204443,2024,FLSLIPKAIKAVSALAKKL,FLSLIPKAIKAVSALAKKL,PSTO2 SR (Phylloseptin-TO2 analog),Free,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 64 µM,Horse,Synthetic Peptide,Helix,NA,CCCGGGGHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13969,39204443,2024,FLSLIPKAIKAVKALAKKL,FLSLIPKAIKAVKALAKKL,PSTO2 SR2 (Phylloseptin-TO2 analog),Free,Free,Linear,L,None,19,"Antibacterial, Antifungal, candidacidal, Anti-MRSA, Anti-sepsis, Hemolytic, Antibiofilm, Anticancer",50 % Hemolytic at 32 µM,Horse,Synthetic Peptide,Helix,NA,CCCSSTHHHHHHHHHHTSSSCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
13970,39138237,2024,FLPFLASLALKIL,FLPFLASLALKIL{ct:Amid},"Temporin-WY2 (Natural AMPs, Leu-rich, frog, amphibians, animals, XXA, UCLL1c)",Amidation,Free,Linear,L,None,13,"Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic",50 % Hemolytic at 32-64 µM,Horse,"Cutaneous Secretion, The Ranidae Frog, Amolops Wuyiensis, China, Asia",Helix,NA,CCCCCCSTTHHHHHHHTSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13971,39138237,2024,FLPKLLSALAKIL,FLPKLLSALAKIL{ct:Amid},"QUB-1426 (Synthetic AMPs, Temporin-WY2 analog, Leu-rich, XXA, UCLL1c",Amidation,Free,Linear,L,None,13,"Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic",50 % Hemolytic at 16-32 µM,Horse,Synthetic Peptide,Helix,NA,CCCCCCGGGGGGTTTCSSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O
13972,39138237,2024,KKKKKKFLPFLASLALKIL,KKKKKKFLPFLASLALKIL{ct:Amid},"6K-WY2 (Synthetic AMPs, Temporin-WY2 analog, Lys-rich, Leu-rich, XXA, UCLL1c",Amidation,Free,Linear,L,None,19,"Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic",50 % Hemolytic at 32 µM,Horse,Synthetic Peptide,Helix,NA,CCSSCCCHIIIIIHHHHSCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
13973,39138237,2024,KKKKKKFLPKLLSALAKIL,KKKKKKFLPKLLSALAKIL{ct:Amid},"6K-1426 (Synthetic AMPs, Temporin-WY2 analog, Lys-rich, Leu-rich, XXA, UCLL1c)",Amidation,Free,Linear,L,None,19,"Antibacterial, Antibiofilm, Anti-MRSA, Hemolytic",50 % Hemolytic at 32 µM,Horse,Synthetic Peptide,Helix,NA,CCCCGGGGGGCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
14149,30734396,2019,LLGMIPVAITAISALSKL,LLGMIPVAITAISALSKL{ct:Amid},Medusin-TR1 (MDS-TR1) (Phylloseptin-4TR) (PLS-4TR),Amidation,Free,Linear,L,None,18,"Antibacterial, Antifungal, Anti-inflammatory, Antibiofilm",50 % Hemolytic at 65 µM,Mouse,Phyllomedusa Trinitatis (Trinidad Leaf Frog),Helical,NA,CCTTTHHHHTCSHHHHHHHHCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O
5805,25891396,2015,AGYLLGKINLKALAALAKKIL,AGYLLGKINLKALAALAKKIL{ct:Amid},TP10,Amidation,Free,Linear,L,None,21,"Antibacterial, Anti-biofilm",80 % Hemolysis at 512 μg/ml,Human,Deletion Analogue Of The Cpp Transportan,α-Helical-50% TFE solution,NA,CTTTSCCCCHHHHHTGGGGTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
5808,25891396,2015,AGYLLGKINLKKLAKL(Aib)KKIL,AGYLLGKINLKKLAKL{nnr:Aib}KKIL{ct:Amid},TP10-5,Amidation,Free,Linear,L,Aib = α-aminoisobutyric acid,21,"Antibacterial, Anti-biofilm",80 % Hemolysis at 512 μg/ml,Human,Transportan 10 Analogues,α-Helical,NA,NA,NA
5809,25891396,2015,AGYLLGKINLKPLAKL(Aib)KKIL,AGYLLGKINLKPLAKL{nnr:Aib}KKIL{ct:Amid},TP10-7,Amidation,Free,Linear,L,Aib = α-aminoisobutyric acid,21,"Antibacterial, Anti-biofilm",59.45 % Hemolysis at 512 μg/ml,Human,Transportan 10 Analogues,α-Helical,NA,NA,NA
6419,27351824,2016,LLPIVGNLLKSLL,LLPIVGNLLKSLL{ct:Amid},TB,Amidation,Free,Linear,L,None,13,"Antimicrobial, Anti-biofilm",0 % Hemolysis at 20-160 μg/ml,Human,Frog Rana Temporaria Skin,α-Helix,NA,CCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
6420,27351824,2016,LLPIVGNLLKSLL,LLPIVGNLLKSLL{ct:Amid},TB,Amidation,Free,Linear,L,None,13,"Antimicrobial, Anti-biofilm",45 % Hemolysis at 320 μg/ml,Human,Frog Rana Temporaria Skin,α-Helix,NA,CCHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C
7173,28559266,2017,VRLIVAVRIWRR,VRLIVAVRIWRR{ct:Amid},IDR-1018,Amidation,Free,Linear,L,None,12,"Antifungal, Anti-biofilm",2.3 - 3.3 % Hemolysis at 32-128 μg/ml,Murine,Variant Of Bovine Hdp Bac2A,NA,NA,CCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
7476,29112170,2017,FLSLIPKIATGIAALAKHL,FLSLIPKIATGIAALAKHL,PSN-PC,Free,Free,Linear,L,None,19,"Antimicrobial, Anti-Biofilm",50 % Hemolysis at 23 µM,Horse,Phyllomedusa Camba Skin Secretion,α-Helical,NA,CCSSSTHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
7477,29112170,2017,FLSLIPKIATGIAALAKHL,FLSLIPKIATGIAALAKHL,PSN-PC,Free,Free,Linear,L,None,19,"Antimicrobial, Anti-Biofilm",~100 % Hemolysis at 64 µM,Horse,Phyllomedusa Camba Skin Secretion,α-Helical,NA,CCSSSTHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
7478,29112170,2017,FLSLIPKIATGIAALAKHL,FLSLIPKIATGIAALAKHL,PSN-PC,Free,Free,Linear,L,None,19,"Antimicrobial, Anti-Biofilm",~100 % Hemolysis at 128 µM,Horse,Phyllomedusa Camba Skin Secretion,α-Helical,NA,CCSSSTHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
7479,29112170,2017,FLSLIPKIATGIAALAKHL,FLSLIPKIATGIAALAKHL,PSN-PC,Free,Free,Linear,L,None,19,"Antimicrobial, Anti-Biofilm",~100 % Hemolysis at 256 µM,Horse,Phyllomedusa Camba Skin Secretion,α-Helical,NA,CCSSSTHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
7480,29112170,2017,FLSLIPKIATGIAALAKHL,FLSLIPKIATGIAALAKHL,PSN-PC,Free,Free,Linear,L,None,19,"Antimicrobial, Anti-Biofilm",~100 % Hemolysis at 512 µM,Horse,Phyllomedusa Camba Skin Secretion,α-Helical,NA,CCSSSTHHHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)O
10338,30951211,2019,Nlys-Ntrp-Nlys-Nlys-Ntrp-Ntrp-Nlys-Ntrp-Nile,{nnr:Nlys}-{nnr:Ntrp}-{nnr:Nlys}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Nile}{nt:H}{ct:Amid},GN-2,Amidation,H,Linear,L,"Nlys = Nlys, Ntrp = Ntrp, Nile = Nile",9,"Anti-biofilm, Antibacterial",<10 % Hemolysis at 128 μg/ml,Human,Synthetic Peptoids Of Gn-2,NA,Low hemolytic,NA,NA
10339,30951211,2019,Nlys-Nlys-Nlys-Nlys-Ntrp-Ntrp-Ntrp-Ntrp-Nile,{nnr:Nlys}-{nnr:Nlys}-{nnr:Nlys}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Nile}{nt:H}{ct:Amid},GN-2-Nlys1-4Ntrp5-8,Amidation,H,Linear,L,"Nlys = Nlys, Ntrp = Ntrp, Nile = Nile",9,"Anti-biofilm, Antibacterial",<10 % Hemolysis at 128 μg/ml,Human,Synthetic Peptoids Of Gn-2,NA,Low hemolytic,NA,NA
10340,30951211,2019,Nlys-Ntrp-Nlys-Nlys-Ntrp-Ntrp-Nlys-Ntrp-Npm,{nnr:Nlys}-{nnr:Ntrp}-{nnr:Nlys}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Ntrp}-{nnr:Nlys}-{nnr:Ntrp}-{nnr:Npm}{nt:H}{ct:Amid},GN-2-Npm9,Amidation,H,Linear,L,"Nlys = Nlys, Ntrp = Ntrp, Npm = Npm",9,"Anti-biofilm, Antibacterial",<10 % Hemolysis at 128 μg/ml,Human,Synthetic Peptoids Of Gn-2,NA,NA,NA,NA
10341,30951211,2019,RWKRWWRWI,RWKRWWRWI{ct:Amid},GN-2,Amidation,Free,Linear,L,None,9,"Anti-biofilm, Antibacterial",<10 % Hemolysis at 128 μg/ml,Human,Synthetic Peptide,"water = α-Helix, TFE = α-Helix",NA,CCGGGHHHHHHHHSCTTTSCCCCCCSCCCSSSCSSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
10342,30951211,2019,RWRRWWRWI,RWRRWWRWI{ct:Amid},"GN-2-Arg1,3,4,7",Amidation,Free,Linear,L,None,9,"Anti-biofilm, Antibacterial",<10 % Hemolysis at 128 μg/ml,Human,Synthetic Analogue Peptide,"water = Random coil, TFE = Random coil",Low hemolytic,CGGGGHHHHHHHHTTTTCSSCCSCSSCCCSSGGGTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O
10343,30951211,2019,KWKKWWKWI,KWKKWWKWI{ct:Amid},"GN-2-Lys1,3,4,7",Amidation,Free,Linear,L,None,9,"Anti-biofilm, Antibacterial",<10 % Hemolysis at 128 μg/ml,Human,Synthetic Analogue Peptide,"water = Random coil, TFE = Random coil",Low hemolytic,CCSSTHHHHHHHHHHHHHTTTSCCTTHHHHHHHTTCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)O
10344,30951211,2019,KKKKWWWWI,KKKKWWWWI{ct:Amid},GN-2-Lys1-4Trp5-8,Amidation,Free,Linear,L,None,9,"Anti-biofilm, Antibacterial",<10 % Hemolysis at 128 μg/ml,Human,Synthetic Analogue Peptide,NA,Low hemolytic,CCSCTTHHHHTTCSSSSTTTSCCCCCCTTSGGGSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
10345,30951211,2019,KWKKWWKWF,KWKKWWKWF{ct:Amid},"GN-2-Lys1,3,4,7Phe9",Amidation,Free,Linear,L,None,9,"Anti-biofilm, Antibacterial",<10 % Hemolysis at 128 μg/ml,Human,Synthetic Analogue Peptide,"water = Random coil, TFE = Random coil",NA,CCGGGHHHHHHHHTTSTTTCCSTTHHHHHHHHHHHTTCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11023,32619153,2020,ITRYLDKILRILRKYLKA,ITRYLDKILRILRKYLKA,Pep-IA18,Free,Free,Linear,L,None,18,"Antifungal, Anti-biofilm",1 % Hemolysis at 450 µM,Human,"Designed From Profilin, A Protein From Insect (Fall Armyworm)Spodoptera Frugiperda","water = Random coil, 50% TFE/water (v/v) and SDS micelle = α-Helix",Non-hemolytic,CHHHHHHHHTCTTHHHHHHHHSCC,CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O
11024,32619153,2020,ITRYLDKILRILRKYLKA,ITRYLDKILRILRKYLKA,Pep-IA18,Free,Free,Linear,L,None,18,"Antifungal, Anti-biofilm",<o.5 % Hemolysis at 225 µM,Human,"Designed From Profilin, A Protein From Insect (Fall Armyworm)Spodoptera Frugiperda","water = Random coil, 50% TFE/water (v/v) and SDS micelle = α-Helix",Non-hemolytic,NA,CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O
11032,32397600,2020,SLWGKLKEMAAAAGKAALNAVNGLVNQ,SLWGKLKEMAAAAGKAALNAVNGLVNQ{ct:Amid},DRP-AC4,Amidation,Free,Linear,L,None,27,"Antimicrobial, Anti-biofilm",10 % Hemolysis at 26.25 µM,Horse,Frog Skin Agalychnis Callidryas(Dermaseptin),"aqueous = Random coil,50%(TFE) = α-Helix",NA,CCHHHHTTCSCGGGTGGGTSSSSCCCC,CSCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C
11033,32397600,2020,SLWGKLKEMLAKAGKAVANAVNGLANQ,SLWGKLKEMLAKAGKAVANAVNGLANQ{ct:Amid},DRP-AC4a,Amidation,Free,Linear,L,None,27,"Antimicrobial, Anti-biofilm",10 % Hemolysis at 14.49 µM,Horse,Analogue Of Drp-Ac4,"aqueous = Random coil,50%(TFE) = α-Helix",NA,CCGGGGCCTTSCGGGTSCCC,CSCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C
11034,32397600,2020,SLWGKLKEMLAAAGKAVANAVNGLANQ,SLWGKLKEMLAAAGKAVANAVNGLANQ{ct:Amid},DRP-AC4b,Amidation,Free,Linear,L,None,27,"Antimicrobial, Anti-biofilm",10 % Hemolysis at 21.53 µM,Horse,Analogue Of Drp-Ac4,"aqueous = Random coil,50%(TFE) = α-Helix",NA,CCGGGTSEEECSSCEEESCC,CSCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)C(C)C
11049,32347293,2020,FLGALFKVASKLVPAAICSISKKC,FLGALFKVASKLVPAAICSISKKC,Brevinin-1GHd,Free,Free,Linear,L,None,24,"Antimicrobial, Anticancer, Antibiotic, Anti-biofilm",13 % Hemolysis at 32 µM,Horse,"Frog Skin, Hylarana Guenther","aqueous(10 mM NH4AC buffer) = Random coil, membrane-mimetic environment (50% TFE in 10 mM NH4AC)membrane-mimetic environment (50% TFE in 10 mM NH4AC) = α-Helix",NA,CTHHHHHHHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC
11092,32334835,2020,QAK,QAK{nt:Amid},QAK,Free,Amidation,Linear,L,None,3,"Antibacterial, Anti-biofilm",12 % Hemolysis at 30 μg/ml,Rabbit,Hemolymph Non-Mulberry Silkworm Antheraea Mylitta,NA,NA,CCC,C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
11093,32334835,2020,QAK,QAK{nt:Amid},QAK,Free,Amidation,Linear,L,None,3,"Antibacterial, Anti-biofilm",18 % Hemolysis at 60 μg/ml,Rabbit,Hemolymph Non-Mulberry Silkworm Antheraea Mylitta,NA,NA,NA,C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
11094,32334835,2020,QAK,QAK{nt:Acet}{ct:Acet},acetylated-QAK,Acetylation,Acetylation,Linear,L,None,3,"Antibacterial, Anti-biofilm",1 % Hemolysis at 3.75 μg/ml,Rabbit,Synthesized-Qak,NA,Low hemolytic,NA,C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
11095,32334835,2020,QAK,QAK{nt:Acet}{ct:Acet},acetylated-QAK,Acetylation,Acetylation,Linear,L,None,3,"Antibacterial, Anti-biofilm",2 % Hemolysis at 7.5 μg/ml,Rabbit,Synthesized-Qak,NA,Low hemolytic,NA,C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
11096,32334835,2020,QAK,QAK{nt:Acet}{ct:Acet},acetylated-QAK,Acetylation,Acetylation,Linear,L,None,3,"Antibacterial, Anti-biofilm",19.55 % Hemolysis at 100 μg/ml,Rabbit,Synthesized-Qak,NA,Low hemolytic,CCHHHHGGGCHHHHHHHC,C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
11097,32334835,2020,QAK,QAK{nt:Acet}{ct:Acet},acetylated-QAK,Acetylation,Acetylation,Linear,L,None,3,"Antibacterial, Anti-biofilm",38.28 % Hemolysis at 200 μg/ml,Rabbit,Synthesized-Qak,NA,NA,CCCSSHHHHHHHHTTTTTCC,C[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O
11168,32654770,2020,AβLLKRIKTLL,{nnr:Aβ}LLKRIKTLL{ct:Amid},Ano-1β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11169,32654770,2020,GAβLKRIKTLL,G{nnr:Aβ}LKRIKTLL{ct:Amid},Ano-2β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11170,32654770,2020,GLAβKRIKTLL,GL{nnr:Aβ}KRIKTLL{ct:Amid},Ano-3β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11171,32654770,2020,GLLAβRIKTLL,GLL{nnr:Aβ}RIKTLL{ct:Amid},Ano-4β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11172,32654770,2020,GLLKAβIKTLL,GLLK{nnr:Aβ}IKTLL{ct:Amid},Ano-5β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11173,32654770,2020,GLLKRAβKTLL,GLLKR{nnr:Aβ}KTLL{ct:Amid},Ano-6β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11174,32654770,2020,GLLKRIAβTLL,GLLKRI{nnr:Aβ}TLL{ct:Amid},Ano-7β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11175,32654770,2020,GLLKRIKAβLL,GLLKRIK{nnr:Aβ}LL{ct:Amid},Ano-8β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11176,32654770,2020,GLLKRIKTAβL,GLLKRIKT{nnr:Aβ}L{ct:Amid},Ano-9β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11177,32654770,2020,GLLKRIKTLAβ,GLLKRIKTL{nnr:Aβ}{ct:Amid},Ano-10β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11178,32654770,2020,AβLLKRIKAβLL,{nnr:Aβ}LLKRIK{nnr:Aβ}LL{ct:Amid},Ano-1β8β,Amidation,Free,Linear,L,"Aβ = β-Ala{nnr:Bala} – β-Alanine , {nnr:Bala} – β-Alanine",10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Modified With Β-Ala In Anoplin,30 mM SDS = α-Helix,Low hemolytic,NA,NA
11179,32654770,2020,GLLKRIKTLL,GLLKRIKTLL{ct:Amid},Anoplin,Amidation,Free,Linear,L,None,10,"Antibacterial, Anti-biofilm",10 % Hemolysis at >256 µM,mouse,Venom Sac Of Solitary Spider Wasps,30 mM SDS = α-Helix,Low hemolytic,CCSCCCCCCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
11180,32630734,2020,FIQHLIPLIPHAIQGIKDIF,FIQHLIPLIPHAIQGIKDIF{ct:Amid},Kassiniatuerin-3,Amidation,Free,Linear,L,None,20,"Antimicrobial, Anti-biofilm, Antiproliferation",~2 % Hemolysis at 160 µM,Horse,Frog Kassina Senegalensis,"aqueous = Random coil, 50% TFE = Helical",Low hemolytic,CCTTTTTHHHHSCCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11538,32786271,2020,KFFKRLLKSVRRAVKKFRK,KFFKRLLKSVRRAVKKFRK{ct:Amid},HC1,Amidation,Free,Linear,L,None,19,"Antimicrobial, Anti-inflammatory, Anti-biofilm",33 % Hemolysis at 50 µM,Mouse,Snake Hydrophis Cyanocinctus,"water = Random coil, 60 mM SDS solution = α-helica",NA,CCHHHHHHHHHHHGGGTCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C
11539,32786271,2020,kFFkrLLkSVrrAVkkFrk,K{d}FFK{d}R{d}LLK{d}SVR{d}R{d}AVK{d}K{d}FR{d}K{d}{ct:Amid},HC1-D1,Amidation,Free,Linear,Mix,None,19,"Antimicrobial, Anti-inflammatory, Anti-biofilm",28 % Hemolysis at 50 µM,Mouse,Hc-Cath Derivatives,"water = Random coil, 60 mM SDS solution = Random coil",NA,CGGGGGGHHHHHHHHCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C
11540,32786271,2020,kﬀkrllksvrravkkfrk,K{d}F{d}F{d}K{d}R{d}L{d}L{d}K{d}S{d}V{d}R{d}R{d}A{d}V{d}K{d}K{d}F{d}R{d}K{d}{ct:Amid},HC1-D2,Amidation,Free,Linear,D,None,19,"Antimicrobial, Anti-inflammatory, Anti-biofilm",31 % Hemolysis at 50 µM,Mouse,Hc-Cath Derivatives,"water = Random coil, 60 mM SDS solution = α-Helix",NA,CTHHHHHHHHHHHHHHHTTSCCCSSCCSCC,NA
11541,32786271,2020,KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL,KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL,Hc-CATH,Free,Free,Linear,Mix,None,30,"Antimicrobial, Anti-inflammatory, Anti-biofilm",37 % Hemolysis at 50 µM,Mouse,Hc-Cath Derivatives,amphipathic α-Helical,NA,CCCHHHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
11542,32786271,2020,KFFKRLLKSVRRAVKKFRK,KFFKRLLKSVRRAVKKFRK{ct:Amid},HC1,Amidation,Free,Linear,L,None,19,"Antimicrobial, Anti-inflammatory, Anti-biofilm",13 % Hemolysis at 50 µM,Human,Snake Hydrophis Cyanocinctus,"water = Random coil, 60 mM SDS solution = α-helica",NA,CCCSSSSSHHHHGGGTCSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C
11543,32786271,2020,kFFkrLLkSVrrAVkkFrk,K{d}FFK{d}R{d}LLK{d}SVR{d}R{d}AVK{d}K{d}FR{d}K{d}{ct:Amid},HC1-D1,Amidation,Free,Linear,Mix,None,19,"Antimicrobial, Anti-inflammatory, Anti-biofilm",9 % Hemolysis at 50 µM,Human,Hc-Cath Derivatives,"water = Random coil, 60 mM SDS solution = Random coil",NA,CCSSCCCTHHHHHHHTCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C
11544,32786271,2020,kﬀkrllksvrravkkfrk,K{d}F{d}F{d}K{d}R{d}L{d}L{d}K{d}S{d}V{d}R{d}R{d}A{d}V{d}K{d}K{d}F{d}R{d}K{d}{ct:Amid},HC1-D2,Amidation,Free,Linear,D,None,19,"Antimicrobial, Anti-inflammatory, Anti-biofilm",12 % Hemolysis at 50 µM,Human,Hc-Cath Derivatives,"water = Random coil, 60 mM SDS solution = α-Helix",NA,CCSSHHHHHHHHHCSSCC,NA
11545,32786271,2020,KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL,KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL,Hc-CATH,Free,Free,Linear,Mix,None,30,"Antimicrobial, Anti-inflammatory, Anti-biofilm",16 % Hemolysis at 50 µM,Human,Hc-Cath Derivatives,amphipathic α-Helical,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
11546,32841003,2020,GITDLRGMLKRLKKMK,GITDLRGMLKRLKKMK,Sm-A1,Free,Free,Linear,L,None,16,"Antibacterial, Anti-biofilm",10 % Hemolysis at 80 µM,Human,Derived From Turbot Viscera Hydrolysate,α-Helix,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
11675,33291521,2020,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anti-biofilm",10 % Hemolysis at 156 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,NA,CGGGTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11676,33291521,2020,FLQRIIRALGRLF,FLQRIIRALGRLF,GHaR7R,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anti-biofilm",10 % Hemolysis at 11.6 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,NA,CCGGGGGTSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11677,33291521,2020,FLQRIIGRLGRLF,FLQRIIGRLGRLF,GHaR8R,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anti-biofilm",10 % Hemolysis at 22.3 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,NA,CTHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11679,33291521,2020,FLQRIIGAWGRLF,FLQRIIGAWGRLF,GHaR9W,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anti-biofilm",10 % Hemolysis at 32.8 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,NA,CHHHHTCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11681,33291521,2020,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anti-biofilm",50 % Hemolysis at >200 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,Low hemolytic,CCCCCCCCCSSSSSSCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
11682,33291521,2020,FLQRIIRALGRLF,FLQRIIRALGRLF,GHaR7R,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anti-biofilm",50 % Hemolysis at 10.9 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,NA,CCCCCCCCCSSSSSSCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11683,33291521,2020,FLQRIIGRLGRLF,FLQRIIGRLGRLF,GHaR8R,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anti-biofilm",50 % Hemolysis at 167.6 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,NA,CCCHHHHTTCCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11685,33291521,2020,FLQRIIGAWGRLF,FLQRIIGAWGRLF,GHaR9W,Free,Free,Linear,L,None,13,"Antibacterial, Antifungal, Anti-biofilm",50 % Hemolysis at 86.3 µM,Human,Synthetic Temporin-Gha (Gha) Analogue,α-Helical,NA,CTTTHHHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
11798,33242568,2021,KKCNFFCKLKKKVKSVGSRNLIGSATHHHRIYRV,KKCNFFCKLKKKVKSVGSRNLIGSATHHHRIYRV,PN-CATH1,Free,Free,Linear,L,None,34,"Antibacterial, Antifungal, Anti-biofilm, Anti-inflammatory, anitoxidant",5.9 % Hemolysis at 200 μg/ml,Mouse,"Black-Spotted Frog, Pelophylax Nigromaculata",SDS = α-Helical,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)O
11799,33242568,2021,EGCNILCLLKRKVKAVKNVVKNVVKSVVG,EGCNILCLLKRKVKAVKNVVKNVVKSVVG,PN-CATH2,Free,Free,Linear,L,None,29,"Antibacterial, Antifungal, Anti-biofilm, Anti-inflammatory, anitoxidant",7.5 % Hemolysis at 200 μg/ml,Mouse,"Black-Spotted Frog, Pelophylax Nigromaculata",SDS = α-Helical,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C
12107,34180670,2021,GLLKRIKTLL,GLLKRIKTLL,anoplin,Free,Free,Linear,L,None,10,"Antibacterial, Anti-biofilm",10 % Hemolysis at ≥512 µM,Human,Venom Of Wasps (Anoplius Samariensis),α-Helical,Non-hemolytic,CGGGTGGGCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)O
12128,34180670,2021,KWWKKWKKWW,KWWKKWKKWW,A-21,Free,Free,Linear,L,None,10,"Antibacterial, Anti-biofilm",10 % Hemolysis at 134.38 µM,Human,Anoplin Analogues,"water = Random coil, 50% trifluoroethanol = α-Helical",NA,NA,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12130,34342438,2021,RPFTRAQWFAIQHISPRTIAMRAINNYRWR,RPFTRAQWFAIQHISPRTIAMRAINNYRWR,hECP30,Free,Free,Linear,L,None,30,"Antimicrobial, Anti-biofilm",44 ± 4 % Hemolysis at 250 µM,Horse,Human Rnase 3 Eosinophil Cationic Protein (Ecp) Fragment,"aqueous = Random coil, SDS micelles (1 mM) = α-Helical",NA,CCCSSSSCCCCCSSCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12719,36903328,2023,KRFKKFFKKLRKSVKKRVKKFFKKPKVIGVSIPF,KRFKKFFKKLRKSVKKRVKKFFKKPKVIGVSIPF,Hydrostatin-AMP2,Free,Free,Linear,L,None,34,"Antibacterial, Anti-biofilm",4.6 % Hemolysis at 250 μg/ml,Human,Sea Snake Hydrophis Cyanocinctus,"Water = Random coil, SDS = α-Helical",Low hemolytic,CCCEEETTEEECCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C
12904,35216177,2022,FVQWFSKFLGRIL,FVQWFSKFLGRIL,Temporin L,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",∼70 % Hemolysis at 100 µM,Human,Rana Temporaria (Red Frog),α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
12905,35216177,2022,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},"[Pro3 , DLeu9 ] TL",Amidation,Free,Linear,Mix,l = D-Leucine,13,"Antibacterial, Anti-biofilm",∼50 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCCCGGGTTTSCC,NA
12906,35216177,2022,FVQWFSKFLGRIL,FVQWFSKFLGRIL,Temporin L,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",∼43 % Hemolysis at 50 µM,Human,Rana Temporaria (Red Frog),α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
12907,35216177,2022,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},"[Pro3 , DLeu9 ] TL",Amidation,Free,Linear,Mix,l = D-Leucine,13,"Antibacterial, Anti-biofilm",∼25 % Hemolysis at 50 µM,Human,Synthetic,α-Helix,NA,CCCCHHHHHHHC,NA
12908,35216177,2022,FVPWFSKFlGRIL,FVPWFSKFL{d}GRIL{ct:Amid},"[Pro3,DLeu9] TL (TL1)",Amidation,Free,Linear,Mix,l=D-Leu,13,"Antibacterial, Anti-biofilm",60 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12909,35216177,2022,FVPWFSKFlPRIL,FVPWFSKFL{d}PRIL{ct:Amid},"[Pro3,DLeu9,Pro10] TL (TL2)",Amidation,Free,Linear,Mix,l=D-Leu,14,"Antibacterial, Anti-biofilm",60 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCCCTHHHHTTTC,NA
12910,35216177,2022,FVPWFSKFlpRIL,FVPWFSKFL{d}P{d}RIL{ct:Amid},"[Pro3,DLeu9,DPro10] TL (TL3)",Amidation,Free,Linear,Mix,"l=D-Leu, p = D-Pro",14,"Antibacterial, Anti-biofilm",20 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12911,35216177,2022,FVPWFSKFlORIL,FVPWFSKFL{d}{nnr:O}RIL{ct:Amid},"[Pro3,DLeu9,Hyp10] TL (TL4)",Amidation,Free,Linear,Mix,"l=D-Leu, O = Hyp = hydroxyproline",14,"Antibacterial, Anti-biofilm",80 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12912,35216177,2022,FVPWFSKFloRIL,FVPWFSKFL{d}{nnr:o}RIL{ct:Amid},"[Pro3,DLeu9,DHyp10] TL (TL5)",Amidation,Free,Linear,Mix,"l=D-Leu, o = D-Hyp = hydroxyproline",14,"Antibacterial, Anti-biofilm",20 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12913,35216177,2022,FVPWFSKFlNRIL,FVPWFSKFL{d}{nnr:N=Nle}RIL{ct:Amid},"[Pro3,DLeu9,Nle10] TL (TL6)",Amidation,Free,Linear,Mix,"l=D-Leu, N = Nle",14,"Antibacterial, Anti-biofilm",60 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCCCHHHHHTTTC,NA
12914,35216177,2022,FVPWFSKFlnRIL,FVPWFSKFL{d}{nnr:n=D-Nle}RIL{ct:Amid},"[Pro3,DLeu9,DNle10] TL (TL7)",Amidation,Free,Linear,Mix,"l=D-Leu, n = D-Nle",14,"Antibacterial, Anti-biofilm",40 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12915,35216177,2022,FVPWFSKFlKRIL,FVPWFSKFL{d}KRIL{ct:Amid},"[Pro3,DLeu9,Lys10] TL (TL8)",Amidation,Free,Linear,Mix,l=D-Leu,14,"Antibacterial, Anti-biofilm",80 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCHHHHTTTCC,NA
12916,35216177,2022,FVPWFSKFlkRIL,FVPWFSKFL{d}K{d}RIL{ct:Amid},"[Pro3,DLeu9,DLys10] TL (TL9)",Amidation,Free,Linear,Mix,"l=D-Leu, k = D-Lys",14,"Antibacterial, Anti-biofilm",40 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCSGGGTGGGC,NA
12917,35216177,2022,FVPWFSKFlWRIL,FVPWFSKFL{d}WRIL{ct:Amid},"[Pro3,DLeu9,Trp10] TL (TL10)",Amidation,Free,Linear,Mix,l=D-Leu,14,"Antibacterial, Anti-biofilm",60 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCGGGTTCSCC,NA
12918,35216177,2022,FVPWFSKFlwRIL,FVPWFSKFL{d}W{d}RIL{ct:Amid},"[Pro3,DLeu9,DTrp10] TL (TL11)",Amidation,Free,Linear,Mix,"l=D-Leu, w = D-Trp",14,"Antibacterial, Anti-biofilm",80 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CCHHHHTTTCC,NA
12919,35216177,2022,FVPWFSKFlAicRIL,FVPWFSKFl{nnr:Aic}RIL{ct:Amid},"[Pro3,DLeu9,Aic10] TL (TL12)",Amidation,Free,Linear,Mix,Aic = 2-aminoindane-2-carboxylic acid,14,"Antibacterial, Anti-biofilm",100 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,NA,NA
12938,35323465,2022,KWCI RVCRNGVCYRRCR,KWCI RVCRNGVCYRRCR,CT5,Free,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",<2.5 % Hemolysis at 128 µM,Human,Synthetic,NA,Non-hemolytic,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O.CC[C@H](C)[C@@H](C=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN
12939,35323465,2022,RVC FRVCRNGVCYRRCW,RVC FRVCRNGVCYRRCW,CT6,Free,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",<2.5 % Hemolysis at 128 µM,Human,Synthetic,NA,Non-hemolytic,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O.CC(C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C=O)CS
12940,35323465,2022,RVCIRVCYRGVCYRRCW,RVCIRVCYRGVCYRRCW,CT7,Free,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",50 % Hemolysis at 128 µM,Human,Synthetic,NA,Low hemolytic,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C)C(C)C
12941,35323465,2022,KWCFRVCYRGICYRRCR,KWCFRVCYRGICYRRCR,Tachyplesin-1,Free,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",<5 % Hemolysis at 128 µM,Human,Synthetic,NA,Non-hemolytic,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
12942,35123230,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",96 ± 2.1 % Hemolysis at 5 μg/ml,Human,Synthetic,NA,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12943,35123230,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",80.5 ± 2.3 % Hemolysis at 2.5 μg/ml,Human,Synthetic,NA,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12944,35123230,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",74.2 ± 2.2 % Hemolysis at 1.25 μg/ml,Human,Synthetic,NA,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12945,35123230,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",59.5 ± 1.8 % Hemolysis at 0.625 μg/ml,Human,Synthetic,NA,NA,CCCCSSHHHHHHHTSSSTTSTHHHHTTSCCCSSSSSCSSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12946,35123230,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",25 ± 1.2 % Hemolysis at 0.312 μg/ml,Human,Synthetic,NA,NA,CCCHHHHGGGTTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12947,35123230,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",6 ± 0.8 % Hemolysis at 0.156 μg/ml,Human,Synthetic,NA,NA,CCCHHHHGGGTTTTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12948,35123230,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.078 μg/ml,Human,Synthetic,NA,Non-hemolytic,CCCTTTHHHHGGGTC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12949,35123230,2022,GIGAVLKVLTTGLPALISWIKRKRQQ,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.039 μg/ml,Human,Synthetic,NA,Non-hemolytic,CCCHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
12951,35335979,2022,FVDLKKIANILNSIF,FVDLKKIANILNSIF{ct:Amid},Temporin-1CEh,Amidation,Free,Linear,L,None,15,"Antibacterial, Anti-biofilm",50 % Hemolysis at 152.6 µM,Horse,Rana Chensinensis,α-Helix,NA,CTTCCHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
12952,35335979,2022,FVDLKKIANILNSIF,FVDLKKIANILNSIF{ct:Amid},Temporin-1CEh,Amidation,Free,Linear,L,None,15,"Antibacterial, Anti-biofilm",92.3 % Hemolysis at 256 µM,Horse,Rana Chensinensis,α-Helix,NA,CCCCTHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC
12953,35335979,2022,FVDLKKIANIINSIF,FVDLKKIANIINSIF{ct:Amid},Temporin-1CEa,Amidation,Free,Linear,L,None,15,"Antibacterial, Anti-biofilm",50 % Hemolysis at 160 µM,Horse,Synthetic,α-Helix,NA,CCSCTTTTTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
12954,35335979,2022,FVDLKKIANIL,FVDLKKIANIL{ct:Amid},T1CEh-t,Amidation,Free,Linear,L,None,11,"Antibacterial, Anti-biofilm",<5 % Hemolysis at 64 µM,Horse,Synthetic,α-Helix,NA,CCSCCGGGTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
12955,35335979,2022,FVDLKKIANII,FVDLKKIANII{ct:Amid},T1CEa-t,Amidation,Free,Linear,L,None,11,"Antibacterial, Anti-biofilm",0 % Hemolysis at 64 µM,Horse,Synthetic,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)O
12956,35335979,2022,KKFVDLKKIANIL,KKFVDLKKIANIL{ct:Amid},T1CEh-KK,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 64 µM,Horse,Synthetic,α-Helix,NA,CCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
12957,35335979,2022,KKFVPLKKIANIL,KKFVPLKKIANIL{ct:Amid},T1CEh-KKP,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",∼1 % Hemolysis at 64 µM,Horse,Synthetic,α-Helix,NA,CCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
12958,35335979,2022,KKWVPLKKIANIL,KKWVPLKKIANIL{ct:Amid},T1CEh-KKPW,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",<10 % Hemolysis at 256 µM,Horse,Synthetic,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
12959,35335979,2022,KKWVPWKKIANIL,KKWVPWKKIANIL{ct:Amid},T1CEh-KKPWW,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",6 % Hemolysis at 256 µM,Horse,Synthetic,α-Helix,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC
12960,35335979,2022,KKWVPWKKKWVPWKKIANIL,KKWVPWKKKWVPWKKIANIL{ct:Amid},T1CEh-KKPWW2,Amidation,Free,Branched,L,None,20,"Antibacterial, Anti-biofilm",63 % Hemolysis at 256 µM,Horse,Synthetic,α-Helix,NA,NA,NA
12981,35538042,2022,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 3.1 µM,Human,Synthetic,α-Helix,Non-hemolytic,CCGGGGGTSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12982,35538042,2022,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 6.2 µM,Human,Synthetic,α-Helix,Non-hemolytic,CCGGGGGTSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12983,35538042,2022,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 12.5 µM,Human,Synthetic,α-Helix,Non-hemolytic,CTHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12984,35538042,2022,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 25 µM,Human,Synthetic,α-Helix,Non-hemolytic,CTHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12985,35538042,2022,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 50 µM,Human,Synthetic,α-Helix,Non-hemolytic,CTHHHHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12986,35538042,2022,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Non-hemolytic,CHHHHHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12987,35538042,2022,FLQRIRGALGRLF,FLQRIRGALGRLF,GHaR6R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 200 µM,Human,Synthetic,α-Helix,Non-hemolytic,CHHHHHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
12988,35538042,2022,FLQRIIRALGRLF,FLQRIIRALGRLF,GHaR7R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",>85 % Hemolysis at 50 µM,Human,Synthetic,α-Helix,NA,CHHHHHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12989,35538042,2022,FLQRIIRALGRLF,FLQRIIRALGRLF,GHaR7R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",50 % Hemolysis at 25 µM,Human,Synthetic,α-Helix,NA,CHHHHHHHHSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12990,35538042,2022,FLQRIIRALGRLF,FLQRIIRALGRLF,GHaR7R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",>100 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CGGGTGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12991,35538042,2022,FLQRIIGRLGRLF,FLQRIIGRLGRLF,GHaR8R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",∼1 % Hemolysis at 25 µM,Human,Synthetic,α-Helix,Non-hemolytic,CGGGTGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12992,35538042,2022,FLQRIIGRLGRLF,FLQRIIGRLGRLF,GHaR8R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",<10 % Hemolysis at 50 µM,Human,Synthetic,α-Helix,Low hemolytic,CGGGTGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12993,35538042,2022,FLQRIIGRLGRLF,FLQRIIGRLGRLF,GHaR8R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",<25 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,Low hemolytic,CGGGTGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12994,35538042,2022,FLQRIIGRLGRLF,FLQRIIGRLGRLF,GHaR8R,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",<50 % Hemolysis at 200 µM,Human,Synthetic,α-Helix,Low hemolytic,CCCCCCCGGGTTTTCSCCTTHHHHSTTTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12995,35538042,2022,FLQRIIGAWGRLF,FLQRIIGAWGRLF,GHaR9W,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 12.5 µM,Human,Synthetic,α-Helix,Non-hemolytic,CCCCCCCGGGTTTTCSCCTTHHHHSTTTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12996,35538042,2022,FLQRIIGAWGRLF,FLQRIIGAWGRLF,GHaR9W,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",∼10 % Hemolysis at 37.5 µM,Human,Synthetic,α-Helix,Low hemolytic,CCTHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12997,35538042,2022,FLQRIIGAWGRLF,FLQRIIGAWGRLF,GHaR9W,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",62.5 % Hemolysis at 100 µM,Human,Synthetic,α-Helix,NA,CHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
12998,35538042,2022,FLQRIIGAWGRLF,FLQRIIGAWGRLF,GHaR9W,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",>100 % Hemolysis at 200 µM,Human,Synthetic,α-Helix,NA,CHHHHIIIIITTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC
13001,35092568,2022,FLSGIVGMLGKLF,FLSGIVGMLGKLF{ct:Amid},SHa,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",50 % Hemolysis at 25 µM,Human,Synthetic,α-Helix,NA,CHHHHIIIIITTC,NA
13002,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 2.812 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13003,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 2.812 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13004,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 2.812 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13005,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",1±0.62 % Hemolysis at 5.625 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13006,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 5.625 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13007,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 5.625 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13008,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",7±0.55 % Hemolysis at 11.25 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13009,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 11.25 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13010,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",1.8±0.9 % Hemolysis at 11.25 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13011,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",52.74 ± 5.94 % Hemolysis at 22.5 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13012,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",2.88 ± 1.24 % Hemolysis at 22.5 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13013,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",2 ± 0.94 % Hemolysis at 22.5 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13014,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",55.07 ± 5.23 % Hemolysis at 45 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13015,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",18.18 ± 7.65 % Hemolysis at 45 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13016,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",7.49 ± 1.20 % Hemolysis at 45 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13017,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",58.93 ± 6.02 % Hemolysis at 90 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13018,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",42.93 ± 4.75 % Hemolysis at 90 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHTTTC,NA
13019,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",44.69 ± 3.73 % Hemolysis at 90 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHIIIIITTC,NA
13020,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",61.64 ± 13.83 % Hemolysis at 180 µM,Human,Synthetic,α-Helix,NA,CCTTHIIIIITTC,NA
13021,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",47.60 ± 7.88 % Hemolysis at 180 µM,Human,Synthetic,α-Helix,Low hemolytic,CHHHHHHHHHHTTCC,NA
13022,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",57.01 ± 8.50 % Hemolysis at 180 µM,Human,Synthetic,α-Helix,Low hemolytic,CTTTHHHHHHHTTTC,NA
13023,35092568,2022,FLSGIVGMLaKLF,FLSGIVGMLA{d}KLF{ct:Amid},[G10a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",64.71 ± 11.34 % Hemolysis at 360 µM,Human,Synthetic,α-Helix,NA,NA,NA
13024,35092568,2022,FLSaIVGMLGKLF,FLSA{d}IVGMLGKLF{ct:Amid},[G4a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",51.15 ± 10.41 % Hemolysis at 360 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
13025,35092568,2022,FLSGIVaMLGKLF,FLSGIVA{d}MLGKLF{ct:Amid},[G7a]-SHa,Amidation,Free,Linear,Mix,a = D-alanine,13,"Antibacterial, Anti-biofilm",58.97 ± 5.51 % Hemolysis at 360 µM,Human,Synthetic,α-Helix,Low hemolytic,NA,NA
13053,35563007,2022,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,Zophobas atratus defensin | P80033.1,Free,Free,Linear,L,None,43,"Antibacterial, Anti-biofilm",0 % Hemolysis at 1 mg/mL,Sheep,Zophobas Atratus,NA,Non-hemolytic,CCCCCCCBSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
13054,35563007,2022,GGYCNSKSVCVCR,GGYCNSKSVCVCR{ct:Amid},Z-d13,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 1 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCSSSSSCCCSSSCSCCCTTTSSSTTCSCCSCCCCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13055,35563007,2022,RGCYCNSKSVCVCR,RGCYCNSKSVCVCR{ct:Amid},Z-d14C,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 1 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCTTSCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13056,35563007,2022,RGCYCNSKSFCVCR,RGCYCNSKSFCVCR{ct:Amid},Z-d14CF,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",<5 % Hemolysis at 1 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCSCCCSSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13057,35563007,2022,RGCRCNSKSVCVCR,RGCRCNSKSVCVCR{ct:Amid},Z-d14CR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",∼1 % Hemolysis at 1 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCCSSTTTCSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13058,35563007,2022,RGCRCNSKSFCVCR,RGCRCNSKSFCVCR{ct:Amid},Z-d14CFR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",<5 % Hemolysis at 1 mg/mL,Sheep,Synthetic,β-Hairpin,Low hemolytic,CCCCCCCCCSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13059,35563007,2022,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,Zophobas atratus defensin | P80033.1,Free,Free,Linear,L,None,43,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.5 mg/mL,Sheep,Zophobas Atratus,NA,Non-hemolytic,CCCCCCCBSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
13060,35563007,2022,GGYCNSKSVCVCR,GGYCNSKSVCVCR{ct:Amid},Z-d13,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.5 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCSSSSSCCCSSSCSCCCTTTSSSTTCSCCSCCCCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13061,35563007,2022,RGCYCNSKSVCVCR,RGCYCNSKSVCVCR{ct:Amid},Z-d14C,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.5 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCTTSCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13062,35563007,2022,RGCYCNSKSFCVCR,RGCYCNSKSFCVCR{ct:Amid},Z-d14CF,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.5 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCSCCCSSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13063,35563007,2022,RGCRCNSKSVCVCR,RGCRCNSKSVCVCR{ct:Amid},Z-d14CR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.5 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCCSSTTTCSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13064,35563007,2022,RGCRCNSKSFCVCR,RGCRCNSKSFCVCR{ct:Amid},Z-d14CFR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 0.5 mg/mL,Sheep,Synthetic,β-Hairpin,Non-hemolytic,CCCCCCCCCSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13065,35563007,2022,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,Zophobas atratus defensin | P80033.1,Free,Free,Linear,L,None,43,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.1 mg/mL,Sheep,Zophobas Atratus,NA,Non-hemolytic,CCCCCCCBSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
13066,35563007,2022,GGYCNSKSVCVCR,GGYCNSKSVCVCR{ct:Amid},Z-d13,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.1 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCSSSSSCCCSSSCSCCCTTTSSSTTCSCCSCCCCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13067,35563007,2022,RGCYCNSKSVCVCR,RGCYCNSKSVCVCR{ct:Amid},Z-d14C,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.1 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCTTSCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13068,35563007,2022,RGCYCNSKSFCVCR,RGCYCNSKSFCVCR{ct:Amid},Z-d14CF,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.1 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCSCCCSSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13069,35563007,2022,RGCRCNSKSVCVCR,RGCRCNSKSVCVCR{ct:Amid},Z-d14CR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.1 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCCSSTTTCSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13070,35563007,2022,RGCRCNSKSFCVCR,RGCRCNSKSFCVCR{ct:Amid},Z-d14CFR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 0.1 mg/mL,Sheep,Synthetic,β-Hairpin,Non-hemolytic,CCCCCCCCCSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13071,35563007,2022,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,Zophobas atratus defensin | P80033.1,Free,Free,Linear,L,None,43,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.05 mg/mL,Sheep,Zophobas Atratus,NA,Non-hemolytic,CCCCCCCBSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
13072,35563007,2022,GGYCNSKSVCVCR,GGYCNSKSVCVCR{ct:Amid},Z-d13,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.05 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCSSSSSCCCSSSCSCCCTTTSSSTTCSCCSCCCCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13073,35563007,2022,RGCYCNSKSVCVCR,RGCYCNSKSVCVCR{ct:Amid},Z-d14C,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.05 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCTTSCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13074,35563007,2022,RGCYCNSKSFCVCR,RGCYCNSKSFCVCR{ct:Amid},Z-d14CF,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.05 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCSCCCSSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13075,35563007,2022,RGCRCNSKSVCVCR,RGCRCNSKSVCVCR{ct:Amid},Z-d14CR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.05 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCCSSTTTCSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13076,35563007,2022,RGCRCNSKSFCVCR,RGCRCNSKSFCVCR{ct:Amid},Z-d14CFR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.05 mg/mL,Sheep,Synthetic,β-Hairpin,Non-hemolytic,CCCCCCCCCSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13077,35563007,2022,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,Zophobas atratus defensin | P80033.1,Free,Free,Linear,L,None,43,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.01 mg/mL,Sheep,Zophobas Atratus,NA,Non-hemolytic,CCCCCCCBSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
13078,35563007,2022,GGYCNSKSVCVCR,GGYCNSKSVCVCR{ct:Amid},Z-d13,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.01 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCSSSSSCCCSSSCSCCCTTTSSSTTCSCCSCCCCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13079,35563007,2022,RGCYCNSKSVCVCR,RGCYCNSKSVCVCR{ct:Amid},Z-d14C,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.01 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCTTSCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13080,35563007,2022,RGCYCNSKSFCVCR,RGCYCNSKSFCVCR{ct:Amid},Z-d14CF,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.01 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCSCCCSSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13081,35563007,2022,RGCRCNSKSVCVCR,RGCRCNSKSVCVCR{ct:Amid},Z-d14CR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.01 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCCSSTTTCSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13082,35563007,2022,RGCRCNSKSFCVCR,RGCRCNSKSFCVCR{ct:Amid},Z-d14CFR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.01 mg/mL,Sheep,Synthetic,β-Hairpin,Non-hemolytic,CCCCCCCCCSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13083,35563007,2022,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,Zophobas atratus defensin | P80033.1,Free,Free,Linear,L,None,43,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.005 mg/mL,Sheep,Zophobas Atratus,NA,Non-hemolytic,CCCCCCCBSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
13084,35563007,2022,GGYCNSKSVCVCR,GGYCNSKSVCVCR{ct:Amid},Z-d13,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.005 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCSSSSSCCCSSSCSCCCTTTSSSTTCSCCSCCCCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13085,35563007,2022,RGCYCNSKSVCVCR,RGCYCNSKSVCVCR{ct:Amid},Z-d14C,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.005 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCTTSCSCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13086,35563007,2022,RGCYCNSKSFCVCR,RGCYCNSKSFCVCR{ct:Amid},Z-d14CF,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.005 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCSCCCSSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13087,35563007,2022,RGCRCNSKSVCVCR,RGCRCNSKSVCVCR{ct:Amid},Z-d14CR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.005 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,CCCCCSSTTTCSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13088,35563007,2022,RGCRCNSKSFCVCR,RGCRCNSKSFCVCR{ct:Amid},Z-d14CFR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.005 mg/mL,Sheep,Synthetic,β-Hairpin,Non-hemolytic,CCCCCCCCCSSSCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13089,35563007,2022,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,FTCDVLGFEIAGTKLNSAACGAHCLALGRRGGYCNSKSVCVCR,Zophobas atratus defensin | P80033.1,Free,Free,Linear,L,None,43,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.001 mg/mL,Sheep,Zophobas Atratus,NA,Non-hemolytic,CCCCCCCBSSSSBC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
13090,35563007,2022,GGYCNSKSVCVCR,GGYCNSKSVCVCR{ct:Amid},Z-d13,Amidation,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.001 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,NA,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13091,35563007,2022,RGCYCNSKSVCVCR,RGCYCNSKSVCVCR{ct:Amid},Z-d14C,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.001 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,NA,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13092,35563007,2022,RGCYCNSKSFCVCR,RGCYCNSKSFCVCR{ct:Amid},Z-d14CF,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.001 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,NA,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13093,35563007,2022,RGCRCNSKSVCVCR,RGCRCNSKSVCVCR{ct:Amid},Z-d14CR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.001 mg/mL,Sheep,Synthetic,β-Sheet,Non-hemolytic,NA,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13094,35563007,2022,RGCRCNSKSFCVCR,RGCRCNSKSFCVCR{ct:Amid},Z-d14CFR,Amidation,Free,Linear,L,None,14,"Antibacterial, Anti-biofilm",0 % Hemolysis at 0.001 mg/mL,Sheep,Synthetic,β-Hairpin,Non-hemolytic,NA,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
13295,35616397,2022,GAIPKCCVGTSRNIPLSILMRVERYDVQHNHGACEIDAWLHANGRKYCADPRVKKVLGVAMQIRKAQLMREKLNSIMRR,GAIPKCCVGTSRNIPLSILMRVERYDVQHNHGACEIDAWLHANGRKYCADPRVKKVLGVAMQIRKAQLMREKLNSIMRR,omCK11,Free,Free,Linear,L,None,79,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 250 μg/ml,Human,Oncorhynchus Mykiss,α-Helix,NA,CCSSTTHHHHHHHHHHHTTGGGTSSCCCC,NA
13296,35616397,2022,AHPKVKRKLKRMQRKKDGKQKRH,AHPKVKRKLKRMQRKKDGKQKRH,omCCL28-like-23,Free,Free,Linear,L,None,23,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 250 μg/ml,Human,Synthetic; Omck11 Analogues,α-Helix,NA,CCSTTSSHHHHHHCSSCCCCSCC,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
13297,35616397,2022,ATPKMEQFLQKLMKRMARLKASAV,ATPKMEQFLQKLMKRMARLKASAV,drCCL27b-24,Free,Free,Linear,L,None,24,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 250 μg/ml,Human,Synthetic; Omck11 Analogues,α-Helix,NA,CCHHHHTTGGGTC,CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C
13298,35616397,2022,AHPKWMEVRSRQRKKKHNKRRATY,AHPKWMEVRSRQRKKKHNKRRATY,IcCCL28-25,Free,Free,Linear,L,None,24,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 250 μg/ml,Human,Synthetic; Omck11 Analogues,α-Helix,NA,CTTHHHHHHHHHC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O)C(C)C
13299,35616397,2022,APLKMKAILEIVHRRMKQNKMKAAF,APLKMKAILEIVHRRMKQNKMKAAF,smCCL27b-25,Free,Free,Linear,L,None,25,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 250 μg/ml,Human,Synthetic; Omck11 Analogues,α-Helix,NA,CHHHHHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
13300,35616397,2022,VDQTVFKDIWWRMKQWKQRVKKRAAKYNV,VDQTVFKDIWWRMKQWKQRVKKRAAKYNV,trCCL28-29,Free,Free,Linear,L,None,29,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 250 μg/ml,Human,Synthetic; Omck11 Analogues,α-Helix,NA,CCCCSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C
13301,35616397,2022,AHPRIKKHLDLLMKKKRHLAMKIAAP,AHPRIKKHLDLLMKKKRHLAMKIAAP,chCCL27a-26,Free,Free,Linear,L,None,26,"Antibacterial, Anti-biofilm",<1 % Hemolysis at 250 μg/ml,Human,Synthetic; Omck11 Analogues,α-Helix,NA,CCCCSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O
13302,35377553,2022,FFGSVLKLIPKIL,FFGSVLKLIPKIL,temporin-PTa,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",13 % Hemolysis at 87 µM,Mus musculus,Hylarana Picturata,α-Helix,NA,CTTSCTTCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O
13303,35377553,2022,AAGKVLKLLKKLL,AAGKVLKLLKKLL,Hp-MAP1,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",Hemolytic,Mus musculus,Synthetic; Temporin-Pta,α-Helix,NA,CCCSSCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C)C(=O)O
13304,35377553,2022,AAKKVLKLLKKLL,AAKKVLKLLKKLL,Hp-MAP2,Free,Free,Linear,L,None,13,"Antibacterial, Anti-biofilm",Hemolytic,Mus musculus,Synthetic; Temporin-Pta,α-Helix,NA,CCCCCCSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(C)C)C(=O)O
13327,35526666,2022,FFSLIPSLVGGLISAFK,FFSLIPSLVGGLISAFK{ct:Amid},Stig (stigmurin),Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",0 % Hemolysis at 150–1.17 µM,Human,Tityus Stigmurus,α-Helix,Non-hemolytic,CTTHHHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13328,35526666,2022,FFSLIPKLVGKLISAFK,FFSLIPKLVGKLISAFK{ct:Amid},StigA8,Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",11.5 % Hemolysis at 9.17 µM,Human,Synthetic; Analog Of Stigmurin,α-Helix,Non-hemolytic,CGGGTHHHHHHHTTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13329,35526666,2022,FFSLIPKLVGKLIKAFK,FFSLIPKLVGKLIKAFK{ct:Amid},StigA18,Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",14 % Hemolysis at 9.17 µM,Human,Synthetic; Analog Of Stigmurin,α-Helix,Non-hemolytic,CCSSCTTTSSCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13330,35526666,2022,FFSLIPKLVGKLISAFK,FFSLIPKLVGKLISAFK{ct:Amid},StigA8,Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",15 % Hemolysis at 150 µM,Human,Synthetic; Analog Of Stigmurin,α-Helix,Non-hemolytic,CTTSCHHHHHHHHHHCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13331,35526666,2022,FFSLIPKLVGKLIKAFK,FFSLIPKLVGKLIKAFK{ct:Amid},StigA18,Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",22 % Hemolysis at 150 µM,Human,Synthetic; Analog Of Stigmurin,α-Helix,Non-hemolytic,CCTTTTTGGGCHHHHTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13332,35526666,2022,FFSLIPSLVKKLIKAFK,FFSLIPSLVKKLIKAFK{ct:Amid},StigA25,Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",100 % Hemolysis at 150 µM,Human,Synthetic; Analog Of Stigmurin,NA,NA,CBTTBSCSCCTTTSSSCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13333,35526666,2022,FFKLIPKLVKKLIKAFK,FFKLIPKLVKKLIKAFK{ct:Amid},StigA31,Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",80 % Hemolysis at 150 µM,Human,Synthetic; Analog Of Stigmurin,NA,NA,CCSHHHHHHHSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13334,35526666,2022,FLSLIPSLVGGSISAFK,FLSLIPSLVGGSISAFK{ct:Amid},TsAP-1,Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",5 % Hemolysis at 160 µM,Human,T. Serrulatus Scorpion,NA,NA,CCSHHHHHHHSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
13335,35526666,2022,FLGMIPGLIGGLISAFK,FLGMIPGLIGGLISAFK{ct:Amid},TsAP-2,Amidation,Free,Linear,L,None,17,"Antibacterial, Anti-biofilm",86 % Hemolysis at 40 µM,Human,T. Serrulatus Scorpion,NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC
13426,35966656,2022,KWKLFKKIHKVGQNIRKGIIKAGPAVAVVGQAAQIAK,KWKLFKKIHKVGQNIRKGIIKAGPAVAVVGQAAQIAK,PEW300,Free,Free,Linear,L,None,37,"Antibacterial, Anti-biofilm",0 % Hemolysis at 50 to 250 μg/ml,Mouse,Synthetic,α-Helix,Non-hemolytic,CCCCSHHHHHHHHHHHTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C)C(C)C)[C@@H](C)CC